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ABSTRACT 
Background 
In low and middle incomes, the majority of patients are diagnosed with advanced 
cancers (stage III and IV) which results in more cancer deaths. Even after a diagnosis of 
breast cancer, many patients do not complete their treatment. The reasons why delays 
in diagnosis and treatment occur are multilevel, involving a combination of patient, 
financial and system-related factors. Sociocultural factors such as stigma may also play 
a role. 
Methods 
For Chapter 1, we examined the experience of women with breast cancer in East 
Africa. (Kenya and Tanzania). We carried out a qualitative study using in depth 
interviews to describe the experience of women with breast cancer and to describe the 
barriers and facilitators to care for women in this region. Women who had completed at 
least a year of treatment were eligible to participate and 28 ladies shared their 
experiences. For Chapter 2, we performed a systematic review to determine the role of 
stigma as a barrier to care for breast cancer diagnosis, treatment and follow up. 
Results 
In Chapter 1, 28 women were interviewed in Kenya and Tanzania. For patients 
who completed a year of treatment, the cost of treatment and expenses incurred was a 
major concern. Family disintegration emerged as a significant theme following cancer 
  
 diagnosis. There was a prevalence of stigma around breast cancer and patients would 
not disclose their status to others in the community for fear of being ridiculed, pitied or 
isolated. A number of patients used alternative medicine resulting in delays in treatment. 
Family support, support groups and spirituality played a major role in facilitating the 
completion of initial care and in reducing psychological morbidity. System factors such 
as poor referral pathways, and inappropriate treatment emerged as minor themes. 
  In Chapter 2, 2372 articles were identified, 202 full text reviews performed and 
data extraction done on 38 studies from Africa and Asia. Anticipated stigma (21/38 
studies,55.3%, CI, 38.3 -71.4%) and perceived stigma (21/38 studies,55.3%, CI 38.3 -
71.4%) were the highest reported. Thirty five out of thirty-eight studies, (92.1%, CI 78.6-
93%), mentioned other socio-cultural factors. The sociocultural factors mentioned in 
decreasing frequency were a) fatalism (65%), b) myths around breast cancer (47.4%), 
c) fear of surgery (39.5%) d) conservatism (34.2%), e) use of alternative medicine 
(28.9%) f) spirituality/religion as a barrier (23.7%) and g) collectivism. Studies that had 
perceived stigma had higher rates of alternative medicine use (48%, 10/21) than studies 
that did not have perceived stigma (6%, 1/17). No other significant differences were 
found between studies that had perceived stigma and those that did not (p=0.21->0.95). 
No other significant associations were found between stigma, sociocultural factors, 
region or groups studied 
Conclusions  
          The sociocultural aspects of breast cancer need to be addressed in order to 
ensure comprehensive management of breast cancer patients and completion of 
  
 treatment.  As programs in the region, mainly run by governments, aim to improve the 
financial access to treatment, it would be critical to include efforts aimed at stigma 
reduction and interventions focusing on the sociocultural re-integration of these patients. 
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CHAPTER ONE 
 
Understanding the experience of women with breast cancer in East Africa: A qualitative 
study in Kenya and Tanzania 
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 ABSTRACT 
BACKGROUND 
 Breast cancer is one of the leading causes of premature death in women in East 
Africa. The majority of patients are diagnosed with advanced cancers (stage III and IV) 
which results in more cancer deaths. Even after a diagnosis of breast cancer, many 
patients do not complete their treatment. The reasons why delays in diagnosis and 
treatment occur are multilevel, involving a combination of both patient related and 
financial factors and system related factors. The aim of the study was to understand the 
experience of breast cancer patients in East Africa, in order to determine the facilitators 
and barriers to diagnosis, treatment and follow up of breast cancer.  
 
METHODS 
 28 patients in Kenya and Tanzania who had completed at least a year of initial 
treatment were invited to participate in the study. A qualitative exploratory study was 
done using semi structured, in depth interviews. Grounded theory was then used to 
analyse and develop themes that emerged from these narratives. 
 
RESULTS 
For these patients who completed a year of treatment, the cost of treatment and 
expenses incurred was a major concern. Family disintegration emerged as a significant 
theme following cancer diagnosis. There was a prevalence of stigma around breast 
cancer and patients would not disclose their status to others in the community for fear of 
being ridiculed, pitied or isolated. A number of patients used alternative medicine 
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 resulting in delays in treatment. Family support, support groups and spirituality played 
a major role in facilitating the completion of initial care and in reducing psychological 
morbidity. System factors such as poor referral pathways, and inappropriate treatment 
emerged as minor themes. 
 
CONCLUSIONS 
 The sociocultural aspects of breast cancer need to be addressed in order to 
ensure comprehensive management of breast cancer patients and completion of 
treatment.  As programs in the region, mainly run by governments, aim to improve the 
financial access to treatment, it would be critical to include efforts aimed at stigma 
reduction and interventions focusing on the sociocultural re-integration of these patients. 
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 Introduction 
Cancer has become a major public health issue in low- and middle-income 
countries (LMIC). By 2020, WHO project that 70% of the 15 million new annual cancer 
cases world-wide will be in developing countries. (ref) This is in contrast to only 15% of 
global cancers recorded from developing countries in 1970. (1) While incidence to 
mortality ratios are low in developed countries, (46%), low income countries have 
incidence to mortality ratios as high as 75% (2). 
Similar trends are seen in breast cancer, which is one of the most common 
cancers affecting women in East Africa. Lack of resources and trained health personnel 
result in African women not having access to cancer screening and early diagnosis. The 
rising incidence of breast cancer in countries with limited resources requires a paradigm 
shift to view cancer as a public health problem with serious cost implications and poor 
outcomes if not prevented or detected early(3). 
In sub Saharan Africa breast cancer patients are 10-15 years younger than their 
western counterparts (4) and the majority are diagnosed with advanced (stage 3 and 4) 
disease (5,6,7,8,9). The reasons behind this are numerous. The socioecological model 
(10) may serve as framework to explain the different factors that influence health 
seeking behaviour of an individual and the levels at which different barriers to care may 
exist. These levels may also serve as loci for interventions to improve these barriers. 
Indeed, successful intervention strategies involve multilevel consideration of all these 
aspects. (Figure 1.1) 
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 FIGURE 1.1: THE SOCIO-ECOLOGICAL MODEL AS ADAPTED TO CANCER CARE 
AND CONTROL 
 
 
 
 
The model serves to explain how an individual’s health has multilayered areas and 
successful interventions require consideration at each of these levels 
 
 
There is little in the literature describing the breast cancer experience of patients 
in East Africa. A recent qualitative study in Uganda describes stigma as a significant 
factor preventing engagement with the health system for breast cancer patients (11).  
Level 4: The Society -
govt policies, societal norms
Level 3: The Community-
value system, local politics
Level 2:Immediate 
relationships-family, friends,social 
networks
Level 1: The Individual
Beliefs, culture and values
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 Whether similar themes come into play in Kenyan and Tanzania setting, is largely 
unknown. The aim of this study was to gain an in-depth understanding of breast cancer 
patients’ experiences and to explore barriers and facilitators in accessing breast cancer 
diagnosis, treatment and subsequent follow up. 
  
Methods 
 
Study Setting:  
Interviews were conducted at two private hospital and one public hospital in East 
Africa. The Aga Khan University hospital Nairobi, Kenya and the Aga Khan Hospital, 
Dar es Salaam, Tanzania act as tertiary referral centres for oncology patients in the 
region who can afford private care. Interviews were also conducted at the Ocean Road 
Cancer Centre, in Dar es Salaam, Tanzania. This is the national public tertiary referral 
hospital for oncology services in Tanzania. The Ocean Road cancer centre caters to 
mainly underserved patients in Tanzania 
 
Eligibility criteria 
Patients had to be female, over eighteen years (legal consent age in East Africa) 
and fluent in Swahili or English, which are the national languages spoken in these two 
countries. Patients who could not speak Swahili or English were ineligible for the study. 
Patients who were too unwell to participate in an interview were excluded from the 
study. Patients with a histological diagnosis of breast cancer who had completed at 
least a year of initial treatment were invited to participate in this study. Any breast 
cancer patient attending the clinic for follow up visits at the Aga khan Nairobi, Dar es 
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 salaam, The Ocean Road Cancer institute or any support groups near these facilities 
was invited to participate in the study. Depending on the stage of the disease, patients 
needed to have completed a year of therapy, which may have included surgery, 
chemotherapy or radiation therapy in different combinations. 
 
Methodology 
Women meeting the eligibility criteria were invited to participate in the study. 
Patients were identified at the clinics at these institutions or at affiliated support groups 
at the different facilities. The primary mode of recruitment was through purposive 
sampling of clinic attendees. A few patients were also identified through a snowballing 
technique. This is where patients are asked to make recommendations about other 
patients who might be interested in participating in the study. 
 
An interview guide was developed (appendix 1) and semi-structured in-depth 
interviews with breast cancer survivors were conducted to determine common themes. 
The questions were designed to explore women’s breast cancer experience from 
diagnosis, management and on to survivorship. They explored patient’s support 
systems and coping mechanisms. Barriers or facilitators to their care were examined. 
Their follow up and current functioning was elicited along with their perceptions of the 
health system and health workers.  
 
Conduct of Interviews 
 
Interviews were conducted in person in a comfortable private setting with the 
primary interviewer and a bilingual research assistant. The patient was assured of 
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 confidentiality and invited to share her candid views on her experience. An audio 
recording was transcribed. Recordings done in Swahili were translated by a trained 
translator to English.  
  
Qualitative Analysis 
 
The interviews were transcribed verbatim and interviews done in Swahili were 
translated into English by a trained professional transcriber and translator. Interviews 
were analysed concurrently with data collection, and triangulation was done to enhance 
understanding of some emerging themes.  
Line by line coding was performed and analysis was done through comparison of 
transcripts after reading and rereading transcripts. Using data software Atlas ti, data 
analysis was done using initial open coding to identify concepts. Data coded using the 
line-by-line approach, was then used to develop an initial conceptual framework around 
breast cancer survivors’ and their experiences of management and survivorship. The 
primary unit of analysis was the breast cancer survivor and the focus was on her 
experiences of cancer diagnosis and treatment. Secondary units of analysis were the 
facilitators and barriers to care and follow up adherence and patient’s perceptions of 
health workers and the health system. The number of items generated from a code 
were explored. Each code was examined to generate an initial item that was assigned a 
descriptor. It was found that a single code could generate more than one item. 
However, if the patient repeated the same phrases more than once in her interview, it 
was regarded as the same item, as the concept had been expressed. Axial coding was 
done to determine the categories and selective coding was done to develop the themes 
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 that emerge. Two coders did the coding independently. The results were then 
compared and consensus was obtained.  
Through a collaborative process, the two researchers independently reviewed 
each transcript and reflected on the themes that emerged. The team then meet to 
discuss what they felt the emergent themes were. After several iterations of this 
process, a code book was developed and used for the subsequent analysis. After the 
initial coding, categories were developed and then subsequently grouped into themes. 
This coding was done through an iterative process of reading and rereading transcripts. 
Peer checking was done to confirm the agreement of the results obtained by the team. 
Cases of disagreement were resolved through discussion.  
 
RESULTS 
28 women were interviewed.  The interviews lasted approximately 30-45 
minutes. The median age of women interviewed was 46, (range 31-72). All patients had 
completed at least a year of treatment with years after treatment ranging from 2 years to 
12 years. Many patients were unaware of the stage of their disease (with no 
confirmatory records present) but all patients had surgery and chemotherapy. Most 
patients had a mastectomy and one patient had breast conservation surgery and one 
patient had a delayed reconstruction after mastectomy.  
 
Barriers to care  
There were multiple barriers to seeking hospital treatment that emerged. 
1) Health System and Financial Barriers (Table 1) 
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 A) Lack of access to health care. (Table 1)  
TABLE 1.1: RESULTS OF BARRIERS TO CARE 
THEMES QUOTE 
1.Lack of Access to care: 
Subtheme: accessibility to 
health workers 
‘As time went by, I have come about 2 or 3 times, in 
this room. It is as if the doctors were not there that 
day, in the clinic. We had to go and look for other 
doctors to help us.’PP23 
 
‘Because there are many patients, and someone 
cannot attend to everyone as they would like, they 
must attend to them as they can. So the services 
are going well’ PP25 
 
Lack of Access to care: 
Subtheme: Transportation 
‘The first challenge is transportation. The hospital is 
in the village and there is no car which goes all the 
way there. If you want to get to Ocean Road you 
must take a private vehicle to get you here. The first 
challenge is transportation, the means to get to the 
hospital’ PP20 
 
‘I was to come on 25th, but because I lacked fare, I 
delayed in coming. I stayed for 3 months. Right 
now, because they told me there is a lump on my 
chest and I need to go for chemo.’ PP22 
Lack of Access to care: 
Subtheme: Non availability 
of drugs/Facilities 
 
 
 
And at that time, medicine was not available here. 
We had to buy it. I think it was not after so many 
doses, I don't know, that the medicine was 
available’ PP23 
‘Other times, medicine, when you get to the 
pharmacy, when you get to the window you are told 
this medicine is not there, go to insurance’ PP23. 
‘What I found challenging was the availability of 
chemotherapy drugs. But I got a lot of support, so 
the drugs would be there, although sometimes you 
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 TABLE 1: Barriers cont., 
 
 
 
 
 
 
would be told that they are not there, but after a 
while they are found so you continue’ 
‘I think so. And then there's only one machine. 
When it gets spoilt, people are told it is not working 
and needs to be repaired, and so you are sent 
away. That is also a challenge’ PP21 
‘When it came to radiotherapy it was difficult 
because there are many patients. You can go there 
in the morning and get treatment after a long time 
since there is only one machine. And sometimes it 
gets spoilt. So, you just have to be patient to until 
you finish’ PP26 
 
2.Financial Burden of 
disease 
So the challenge came about from not having 
health insurance. So it means, while undergoing 
treatment, everything required money’ PP28 
 
‘And when you see the situation, has become 
challenging. Cost of living is challenging, even 
finding that money.’ PP24 
 
‘When you get to insurance, you are told the 
medicine is being sold at tsh 100,000 or tsh 
150,000 to tsh 200,000. And you don't have the 
money. How do you treat yourself?’ PP20 
3.System Barriers: Sub 
Theme. Healthworker 
misinformation 
 
 
 
 
After delivering, I noticed the lump growing and felt 
some pain. I went to hospital and explained myself. 
I was told, it is possible it is a boil. Continue 
breastfeeding. Don't be afraid. So I continued 
breastfeeding till the age he stopped. When I 
stopped the lump did not go. I continued waiting’ 
PP08 
 
12 
 
 Table 1: Barriers cont., 
System Barriers: Sub 
theme. Health system 
inefficiencies 
 
 
 
 
What happened is that after they tested, the doctor 
sent me back to them to test whether I am not 
positive. Whether the tumour was something 
positive or negative. And I don't know whether they 
had thrown away the sample or something, he was 
very hostile. Up to date I don't know whether I am 
positive or what.’ PP 07 
 
‘So, I came for a blood test, then went to Room no. 
1 and our names called out twice, my name was not 
one of them. I was told, go back to the laboratory. I 
went there and they could not find my results. They 
checked elsewhere and could not find it. They told 
me, let us test you again’ PP23 
 
‘I told her, they claimed that they do not have the 
results from the sample that was taken to 
“Muhimbili”. Every time I go, I am told to return on a 
certain date. Till the day I went there last, they 
suggested I undergo another operation’ PP23 
 
System Barriers: Sub 
theme. Health worker 
Negativity 
Somewhere else, not in Aga Khan. But there is a 
doctor who asked me, why are you wasting your 
time? You are at stage 4, late, why are you wasting 
your time?’ PP08 
 
 
 
 
This was reflected in the lack of both physical and human resources that were 
available to patients. In the public health system, patients reported lack of availability of 
doctors to cater to them. The participants (PP) noted that when doctors were available, 
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 they were frequently few and having to attend to many patients (PP023, PP025). 
Access to tertiary referral centers was also over long distances and participants noted 
that the costs to reach the tertiary health facility were great (PP020, PP022). Access to 
radiotherapy and chemotherapeutic agents and other medication was also noted to be a 
challenge in this setting. Participants frequently had to pay out of pocket for medication 
that was not available in the institution (PP023, PP21, PP26). 
 
B) Financial burden of cancer. (Table 1) 
The cost implications of treatment were a dominant theme among participants 
interviewed. This frequently related to patients having to pay largely out of pocket to 
finance their treatment. There were high costs of medication and treatment with many 
people not having health insurance and having to rely on family and friends to support 
their treatment (PP020, PP024, PP028). 
 
C) System barriers to care. (Table 1) 
Delays in diagnosis, misdiagnosis or inappropriate assurances resulted in delays 
in patients receiving the care they needed. On reporting a lump, some participants were 
either given medication like antibiotics or as in the case of one lactating mother, who 
was simply asked to just continue breastfeeding (PP08).  Inefficiencies in systems and 
poor referral pathways from initial providers played a role in delaying treatment. 
Participants had their samples discarded (PP07) or had missing test results (PP023). 
One participant was asked to return to the lab, a long distance from her home several 
times until personnel finally admitted that they had misplaced her histology results 
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 (PP023). Perceptions of health workers could also influence patient’s outlook and 
willingness to receive treatment. In some instances, participants with advanced disease 
were discouraged from getting treatment for their cancer (PP08). 
 
2) Patient mediated barriers 
A) Negative family influence and socio-cultural barriers to care. (Table 1.2) 
Socio-cultural factors had a huge influence on the breast cancer patients. 
Negative perceptions of treatment weighed on patients and acted as a source of 
discouragement. Sociocultural factors included fatalism, myths around cancer and its 
treatment and social stigma. All these caused considerable distress amongst patients. 
Patients were discouraged from receiving treatment (PP024) or told that treatment 
would have grave consequences to them including death (PP25).  
 
TABLE 1.2: NEGATIVE FAMILY INFLUENCE AND SOCIOCULTURAL BARRIERS 
TO CARE 
THEME QUOTES 
Sociocultural barriers 
Subtheme: Negative 
family influence 
‘Yes. Even my husband also told me not to go to 
hospital, you will die’ PP24 
 
‘Coming here, people say, radiation burns, radiation 
has this, radiation kills’ PP25 
Sociocultural barriers 
Subtheme: Fatalism 
 
 
‘Many of them discouraged me by telling me that 
cancer has no treatment. So you are a corpse-in-
waiting. And it reached a point at my workplace, there 
was one colleague who died. Many people thought it 
was me who had died. So the discouraging bit is when 
people tell you there's no cure for this, people believe 
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 TABLE 1.2 sociocultural 
barriers cont., 
that cancer cannot be cured. Once you have it, you 
just die.’ PP19 
 
'There are those who take the problem like, ah, this 
one ,Let us just sit with this one…but we can bury her 
at any time'  PP22 
 
Sociocultural barriers 
Subtheme: Myths around 
cancer 
 
 
'That one, some say I got it sexually. It is sexually 
transmitted. That is not the case. It is a normal disease 
that has been sent by the devil, or by God, we don't 
know. Because it affects the small, the big, the old, the 
young' PP21 
 
 
Sociocultural barriers 
Subtheme: Stigma 
 
 
 
 
 
 
 
 
 
 
‘Yeah when I went back to work, it was like, oh she 
can't do this. I said, why? Give me something and we 
see if I can't deliver. But my immediate boss was like, 
no. Even when the project was over, actually she 
signed and said, no, we don't want XXX in the next 
project. Because maybe she will again fall sick and we 
are, you know, that kind of thing. So I missed that 
opportunity.... So there is that kind of 
stigmatization....PP15  
 
The emotions come to mind why I'm like this? Now I 
have two breasts, now I have one. I lost one breast. I 
don't know what the people saying about me, how they 
feel. My relatives start to see me like something not 
good. I feel so bad because I was not getting any 
encouragement from the family. Instead of family say, 
Ah! Why you are like this? You lost one breast, now 
see how you are looking. I feel very bad. Every time I 
was anxious. They didn't give me even the word 
for…for comfort my heart. I feel very bad. PP02 
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 Cont., Sociocultural 
barriers 
Subtheme: Stigma 
 
 
Because when someone saw me it's as if they were 
pointing a finger at me, saying this woman does not 
have a breast. I didn't like sitting, in the evenings we 
usually sit with my husband. In the evenings, we have 
a grocery at home, we sit there and chat and 
customers drink. But after the operation, I didn't want 
to because when they came they would know I did not 
have a breast. It bothered me a bit. Also some time 
when I saw people talking, I would think they are 
talking about me not having a breast. So it bothered 
me. PP04  
 
….here the awareness is low. That is why when we come 
for cancer support groups for so many weeks, there are 
people who have not even told their mothers…..They have 
not told her because of how she will receive the news. 
The education is not good. Still, people here, when 
someone hears, they only see death. And I hear many 
of them when they talk, when they are discussing 
someone. Even others, when we are together, they 
say, so and so has cancer. They just explain as if 
someone is dying. But I can't tell them that I also have 
that problem. Mostly I just comment, that we need to 
check our health….Like in my case, very few people 
know I have cancer.PP013 
 
Sociocultural barriers 
Subtheme: Family 
disintegration 
 
 
 
 
 
Q: Are you married? 
A: I'm married but when I had this thing, my husband 
says because they will take away the breast, I am no 
longer with you. (cries) PP02  
 
..There were so many challenges. One, coping with a 
new born baby and then the worst part is that before I 
could even recover fully, my family broke down, that 
was the most challenging thing…..My family just broke 
down, and we thought it is the end of it all and it’s in 
my opinion when cancer catches up with a young 
couple, the other person should be part of, should be a 
patient also, should be a patient. Actually it shouldn't 
17 
 
 Cont., 
Sociocultural barriers 
Subtheme: Family 
disintegration 
be a voluntary thing it should be part of, because I 
think he feared, he thought I would die, and look for 
another lady to bring up the children, you know, that 
was the talk at least. Like you know, him he could see 
death and so as much as I was sick, I think in my 
opinion today, he was more sick then me. PP07 
 
The hindrance maybe is my husband… 
He thinks it is a normal disease. Then he despises me. 
Because you can't go to theatre, cut a part of your 
body, then you hear your partner telling you, you are 
pretending, so that your brothers can sympathize. You 
are pretending, neither are you in pain. How would you 
feel? If you go to theatre, do you really pretend? Does 
sickness pretend? And I wanted to make a step so 
that my children can carry their mother, what can they 
do? But now they find I've sunk low, so he disrespects 
you.PP05 
 
 
Lack of awareness of 
disease 
“It was 1993, when I found a lump on my right breast 
but I didn't recognize it as a disease’ PP24 
 
‘I didn't know these were the results and they were 
bad.’ PP08 
 
Alternative  
Medicine 
 
 
 
 
I was told to eat a lot of carrot, a lot of leafy 
vegetables, pawpaw, staple food, and take the liquid 
from boiled cabbage, as well as the juice from boiled 
pepper, after washing and boiling, I drink the juice and 
‘mabuyu’ (local seeds from baobab) PP03  
 
I have now I started to have you know, some leaves 
they told me it is a herbal leaf, these leaves are very 
sour, so I am taking those leaves also. And I am 
okay... these herbs you know they are very good 
leaves, you know, they are very sour. So they say sour 
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 Alternative  
Medicine cont., 
 
 
 
 
 
 
 
 
 
is better with, because it goes with the body. So I 
started…. I got a car, we go and pick some, then you 
can, it really helps these herbs. 
Q: How did you find out about it? 
A: Somebody told me you know, they eat these, it 
works great you know. 
Q: So the herbs helped with the cancer? 
A: Cancer spreading yah.                         PP05  
 
…It wasn't easy for me to accept the chemotherapy 
treatment. I was doing a lot of research too, trying to 
understand, what it is, what are the consequences, 
what are the side effects? And I was kind of worried, I 
didn't like to go through the treatment. So I opted for 
alternative, kind of self-treatment with some herbalists 
for many years. But things wouldn't improve much until 
I think 2012,Or was it 2009?By then I was doing my 
PhD in America. I came in 2009. PP17 
 
 
 
 ii) Fatalism. The underpinnings of these perceptions were in the fatalistic views around 
breast cancer. Cancer was seen by participants’ families and friends as a death 
sentence. Participants frequently felt that those around them were just waiting for them 
to die (PP022). 
 
iii) Stigma and myths around cancer. Stigma was prevalent among the participants’ 
families with narratives around self-stigma and anticipated stigma, enacted stigma and 
perceived stigma being seen in participants’ interactions with family and colleagues. 
Some of the genesis of stigma were in the myths around breast cancer. These 
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 narratives had to do with the perceived promiscuous nature of those with cancer 
(PP021) or due to witchcraft. Participants faced stigma either socially or at the work 
place with some participants missing out on employment opportunities (PP015). 
Anticipated stigma was high and participants would avoid disclosure of their cancer 
status in order to avoid being ostracized and would only share the diagnosis with a 
partner or only one or two close family members. This resulted in social isolation for 
participants (PP04, PP13).  
 
iv) Alternative Medicine. Participants used alternative medication to either supplement 
conventional treatment (PP03, PP05) or as a substitute for treatment resulting in delays 
in care. (PP17) 
 
B) Family disintegration. Family disintegration following a diagnosis of cancer was 
common with participants noting a lack of spousal support (table 2). The immediate 
family was frequently the first casualty of a cancer diagnosis the lack of spousal support 
extended from disapproval, abuse (PP05) or abandonment (PP02, PP07).  
 
C) Lack of awareness of disease Lack of knowledge about breast cancer resulted in 
some participants ignoring symptoms. Many participants were initially not aware that 
breast cancer was a problem and thus did not seek any medical attention for their 
condition (PP08, PP24). 
 
 
 
 
 
 
20 
 
 Facilitators to Care 
 
1. Breast awareness 
 
Knowledge of breast cancer symptoms resulted in positive health seeking behaviour for 
some participants.  
 
‘Because there was a place we read and were told that if you see a lump on your body, 
then know it is cancer. So I asked myself and thought it is best to go to hospital’ PP25. 
 
Sometimes a family history of breast cancer would prompt this health seeking behavior. 
 
‘And because of my mother’s experience who had been diagnosed in 2001, I had read a 
lot about cancer so I went to see a doctor’ PP 07 
 
The practice of breast self examination also raised breast awareness in this setting 
 
‘I felt a small lump on my left breast but, which when I press it, it led to my nipple 
removing blood. It was small. I got shocked and went to hospital for investigations’ 
PP26 
 
‘I was just doing the normal checks that we had been taught how to self-check. And I 
realized a lump on one of my breasts for some time and then.’ PP09 
 
 
 
 
2. Social support structures 
 
a) Family support. Family support was critical in helping patients complete their 
treatment. This support was both financial or emotional support. 
 
‘Those who help me are my brothers and they are far. Other days, other times, you 
know how things are. Life is hard. Everyone has their problems. Therefore, if they can 
help, they help. Other times they give me bus fare to come to hospital’ PP23 
 
‘When I went back home to tell my sister, she told me when the date reaches, we go 
together. We went. When we got there, she said, this lady cannot have another surgery. 
We do not have the results of the sample that was taken to Muhimbili. And till now, she 
is in pain. Give me a transfer I take her to Muhimbili’ PP23 
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b) Social networks–Social support structures whether it was from support from church 
groups, from employers, support groups or friends all played a great role in improving 
the outlook of the patients who completed their treatment 
‘Then church groups they were always there. They used to come to my house and pray 
with me and then when I needed financial support, the same group, the family and the 
church group were the major supporters.’ PP09 
 
‘Many times, they encourage me to have faith because there's nothing that defeats God. 
One day you'll be healed. There's nothing impossible with God. Follow the instructions 
and you'll be fine.’ PP18 
 
‘That time I didn't even know this support group but I also met some people who had 
gone through cancer earlier. They just found their way to my house. So they explained 
to me, I learnt a lot and I can say in the beginning those people gave me more strength 
than anything else, because I had to tell them now show me where you were operated, I 
don't know why I was just not believing. But they talked to me a lot about support group, 
actually they were the first group to introduce me to the Kenya Breast Cancer 
Association’….  
 
‘Currently I am a member of Faraja support group. That is the only group that I am in. 
And in that particular set-up I've been able to meet different people who've gone 
through the same thing. Even experienced more than I have because in the group you 
meet many people who have maybe had recurrent cancers once or twice and there are 
those who've had it even for many years than me. And so when you such people you 
find encouragement because they try to explain to you what they've gone through and 
you realize you've not even had half of what they've experienced.’ PP09 
 
c) Physician support - Physicians played an important role in encouraging patients to 
continue their treatment 
‘The first thing that gave me the spirit to be able to go through the treatment, as I said 
earlier, I got a very nice oncologist. A lady, and there is this one statement that she 
made and it got into my head; "the doctors will only do 30%, the 70% it's you and your 
God. And it is all in the mind. And cancer is not a death sentence. Only you are lucky at 
least" and she used this statement, "You are lucky at least you got it earlier, it's not 
spread. So we need to do the treatment and you'll be fine." So that actually, it was like 
an assurance that I need to fight, I need to be positive, every step I take I am sure I am 
getting out of it. So that is what encouraged me.’ PP09 
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 ‘So the doctor urged me that when the wound heals, you do a mastectomy so that it 
does not spread. I was very sad because I had 2 small children, and I saw they were 
still small, I was sad but when they gave me the advice that: having cancer is not a 
death sentence, they took me through a seminar, I agreed with then, so I accepted the 
condition. I agreed and accepted.’ PP01 
 
d) Spousal support - Spousal support was critical in helping patients achieve a positive 
outlook to their disease. 
‘He is very much OK. First, he is very proud, he told me I'm very strong and all that. And 
you know something, he just looks at me as normal, like I have both breasts. It's very 
strange. You know it's like I'm watching a movie’.  PP014 
 
3. Access to financial resources and preparedness 
 
Possession of health insurance and having access to a health insurance scheme was 
an important factor in patient’s willingness to seek care.  
‘For now, I am employed. My company helps me. But the insurance caters for me 
because of this medicine.’ PP26 
 
“I said this time I met someone from the insurance. I encountered an obstacle because 
the cost of medication was very high beyond their capacity, so they were stuck. But I 
think they sorted it out later and I was able to continue with treatment.” PP10 
 
Access to private institutions and having funds to pay for private care reduced delays. 
 
‘You know Nairobi hospital is a private hospital, where you pay a lot of money. So there 
is no delay. People who are delayed are the ones who go to public hospitals.’PP20 
 
 
 
 
 
4. Personal factors as a coping mechanism 
 
a) Spirituality - Many patients relied on spirituality as a way to make sense of their 
cancer journey and as an anchor through the challenges they faced. 
 "You know, when you are going through a condition like this, you really need God, it 
doesn't matter which religion you are. I'm not saying that I'm very good Christian than 
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 anybody else. I'm not saying that I'm praying a lot. Some people tell me, oh you need 
to teach me how to pray. No. I'm only insisting that you need to look at God." PP17 
 
 
b) Resilience 
 
A positive outlook to the experience helped to facilitate completion of care for patients. 
Cancer was viewed as a character building event from which they emerged stronger. 
 
 "...Looking back I think I am a better person. I am a better person because I've learnt 
now how to love more, to have time for everyone, to look into people and not even 
judge them, and I now feel like I have been given another chance by God and so I 
always feel like I want to go out and you know, give back to society..."PP10 
 
 
 
 
 
 
DISCUSSION 
 
In order to understand why women in East Africa are diagnosed with advanced 
disease and frequently do not complete their treatment, we sought to describe the 
experience of women with breast cancer and identify the facilitators and barriers to care 
amongst women who had completed at least a year of treatment. Sociocultural barriers 
such as stigma, fatalism and myths around cancer were pervasive in this setting and 
were a considerable cause of distress for patients. Family disintegration was a major 
theme following a diagnosis of cancer. Financial costs and transportation were also 
major barriers. Facilitators to completion of care included having a comprehensive 
insurance plan and good social support.  
Factors causing delays in care can be broadly divided into patient mediated and 
system mediated factors (12). Patient factors include lack of knowledge among patients, 
the health seeking behaviour of patients, stigma associated with a diagnosis of cancers 
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 and a lack of financial means (12). System barriers include poor available hospital 
resources for the diagnosis and treatment of cancers and a lack of knowledge amongst 
health workers (12,13,14). 
 
System factors 
Fragmentation of care was common with many patients seeing a number of 
doctors before a definitive diagnosis was made. Poor referral pathways also resulted in 
delays in treatment. Different aspects of cancer treatment were only available at specific 
centres, with patients having to travel between these for their care. While this may be a 
reflection of the scarce resources available, the logistics of navigating these referrals, 
frequently over long distances, could contribute to delays in treatment. This suggests a 
need to decentralize care from a single source centre and move towards building 
regional centres of excellence.  
Poor health worker knowledge or false reassurance also resulted in patient 
delays before a diagnosis was made. This is in keeping with finding in the continent 
where Price and colleagues in Cameroon found that breast cancer patients, among 
other patients, would see on average four health workers before being referred to 
appropriate oncology services (15) Many patients who could afford   private treatment, 
consulted multiple doctors before finally seeking treatment abroad then returning home 
for follow up. While this may speak to a lack of available resources locally, (less so for 
those with private insurance), this may also reflect a deeper mistrust of health workers 
and systems which can only be alleviated by enhancing health worker knowledge and 
training in breast health.  
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Patient mediated Factors 
Finances.  
The financial burden of cancer care was a prevalent theme in our study. Our 
patients, like those in many parts of Africa (16), frequently had to pay out of pocket for 
their health expenditure.  In this study, women would rely on friends or family to help 
them meet their treatment costs or defer treatment until funds were available. A lack of 
awareness of breast cancer signs and symptoms also led to delays in seeking help. A 
recent survey of knowledge of breast cancer amongst 225 women attending hospitals in 
Dar es Salaam, showed that only 30% of risk factors and 51% of breast cancer 
symptoms were identified correctly. (17) 
 
Stigma and other sociocultural factors 
Sociocultural factors like stigma, myths around cancer and fatalism were 
prominent in these population and were a considerable cause of psychic distress in 
patients. The Dar survey revealed that, between 70- 82% of women subscribed to one 
or two myths about breast cancer (17). In looking closer at these sociocultural barriers, 
one begins to gain a deeper understanding of reasons why patients may present late 
with advanced disease.  
Fear of stigmatization with subsequent family disruption or fragmentation may cause 
women to delay their health seeking behaviour. Our narratives show that this is a very 
legitimate concern in this setting with several women having their marriages disrupted, 
loss of livelihood and psychological distress, in the background of heightened distress 
26 
 
 due to a cancer diagnosis. Similar findings were seen in Nigeria where a 3-year, post 
diagnosis review, of 88 breast cancer patients showed a divorce rate of 39 % in 
comparison to a national divorce rate of 2% (18). Figure 1.2 provides a summary of the 
different barriers described in the study, within the context of the socio-ecological model 
approach.  
 
FIGURE 1.2: SUMMARY OF BARRIERS IDENTIFIED USING A 
SOCIO_ECOLOGICAL FRAMEWORK 
 
 
 
Barriers to treatment as identified in the study and applied to a socio-ecological model. 
Interventions at these different levels would be required.  
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 To counter these barriers, we propose a multilevel approach that could help to 
improve the experience of breast cancer patients. In both countries studied, a national 
hospital insurance fund exists that caters to patient’s financial needs. The national 
hospital insurance fund in Kenya has only been expanded to cover the cost of cancer 
treatment in the last three years. The impact of this has resulted in more patients 
receiving care but the long-term effects of this are largely unknown. However, in both 
systems, even when financial care is available, lack of equipment, medication stock 
outs still lead to delays in care. Even more far reaching may be the lack of awareness 
and inappropriate counsel provided by health workers which would serve to delay timely 
diagnosis and treatment. Interventions at the individual level and organizational level 
are required.  
Individual interventions might involve patient education, microfinance initiatives to 
complement government funding and strengthening the role of family and support 
groups. Health worker education, especially targeting primary healthcare nurses, may 
be useful in strengthening referrals. Decentralizing care through developing regional 
centres of excellence, will decrease travel and waiting times at key facilities. 
Development of clear, well understood, bidirectional referral pathways will ensure that 
these centres are not congested and appropriate care given at each level. Investment in 
electronic health records and centralized stores will help to monitor medication flows 
and to prevent stock outs. 
  Community awareness can be increased through media campaigns, using 
opinion leaders at local levels like clan elders to spread the message. Uprooting the 
pervasive element of fatalism can only occur through shifting narratives and 
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 encouraging survivors to share testimonials that work at removing both the stigma of 
cancer by discussing it openly and in enhancing perceptions that cure is possible. 
Education of traditional and spiritual healers and leveraging them into referral pathways 
could also help minimize delays. 
 
 
Limitations 
 
While qualitative data in this study are representative of both private and public 
health systems, it was not possible to interview patients from the public health system in 
Kenya. This is because for the period of the study, the public health systems were on 
strike. As health ecosystems differ, the results of our findings may not be generalizable 
to different countries. The authors maintain that there may be common themes in 
regions and these may be similar to findings in the Eastern Africa regions. Though 
regions may differ due to cross-cultural differences, many of the socio-cultural themes 
are applicable across many low and middle-income countries. 
 
 
Conclusions 
 
This manuscript serves to inform on the barriers and facilitators to care for 
women in East Africa with breast cancer. More needs to be done to improve health 
worker awareness and poor system referrals that result in delayed management of 
patients. The factors that were most disruptive were the socio-cultural factors such as 
stigma, which resulted in family disintegration. In patients who had good social support, 
even in the absence of personal financial resources, patients were able to complete 
their care. As efforts like the national hospital insurance funds are increasingly 
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 strengthened in different countries in the region, it is important to consider nationwide 
interventions aimed at reducing stigma and ensuring successful reintegration of breast 
cancer survivors into their communities. 
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CHAPTER TWO 
THE ROLE OF STIGMA IN DELAYS IN THE MANAGEMENT OF BREAST CANCER 
IN LOW AND MIDDLE-INCOME COUNTRIES: A SYSTEMATIC REVIEW 
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 Abstract:  
In low and middle income countries, the majority of the women with breast 
cancer present with advanced cancers (stage 3 and 4 cancers).  A combination of 
patient related and system related barriers result in delays in the diagnosis, treatment 
and follow up of breast cancers. Socio-cultural factors like stigma may play a role in 
patient delays.  The aim of the study to determine the role of stigma as a barrier to care 
for women with cancer in low and middle income countries, and to determine what 
interventions have been tried to mitigate stigma in this setting and to determine the 
effectiveness of these strategies   
 
Methods:  
A search strategy was developed with a medical librarian. The librarian then 
performed a comprehensive search of several databases. These included OVID 
Medline, OVID Embase, CINAHL, Cochrane, and PsycINFO. Subject headings and key 
words were adapted for the other databases. No restrictions on language, the 
publication date, or type of article were placed 
 
Results.  
2372 articles were identified, 202 full text reviews performed and data extraction 
done on 38 studies from Africa and Asia. Anticipated stigma (21/38 studies,55.3%, CI, 
38.3 -71.4%) and perceived stigma (21/38 studies,55.3%, CI 38.3 -71.4%) were the 
highest reported. Thirty five out of thirty-eight studies, (92.1%, CI 78.6-93%), mentioned 
other socio-cultural factors. The sociocultural factors mentioned in decreasing frequency 
were a) fatalism (65%), b) myths around breast cancer (47.4%), c) fear of surgery 
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 (39.5%) d) conservatism (34.2%), e) use of alternative medicine (28.9%) f) 
spirituality/religion as a barrier (23.7%) and g) collectivism. Studies that had perceived 
stigma had higher rates of alternative medicine use (48%, 10/21) than studies that did 
not have perceived stigma (6%, 1/17). No other significant differences were found 
between studies that had perceived stigma and those that did not (p=0.21->0.95). No 
other significant associations were found between stigma, sociocultural factors, region 
or groups studied. 
. 
Conclusion 
Stigma in breast cancer continues to be prevalent in different populations across 
low and middle incomes globally. Urgent interventions are required as part of a multi-
level plan to curb advanced disease at diagnosis of breast cancer and treatment 
discontinuations seen.  These interventions will require an in depth understanding of the 
socio-cultural factors at play in that particular environment. 
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 Introduction: 
Over half a million women die annually of breast cancer, two thirds of whom live 
in low and middle-income countries (1).  In these countries, the majority of the women 
with breast cancer present with advanced cancers (stage 3 and 4 cancers). (2) Early 
diagnosis and treatment is critical to reduce the morbidity and mortality of breast cancer. 
A combination of patient related and system related barriers result in delays in the 
diagnosis, treatment and follow up of breast cancers. (3). In low resource settings, 
patients are diagnosed late, and many do not complete their treatment. Socio-cultural 
factors like stigma may play a role in patient delays (4) 
 
Understanding why patients are diagnosed late with breast cancer in low 
resource settings requires a multilevel approach. Delays are caused by factors which 
can be broadly divided into patient mediated and system mediated factors. (3,5) Patient 
related barriers include stigma and other socio-cultural factors and the lack of financial 
means. Patient mediated factors include socioeconomic factors like the level of 
education or employment status of women (6). This may influence the knowledge 
women have about the risks of breast cancer and their ability to access care. They also 
include socio-cultural factors like stigma, fatalism where there is the belief that death is 
inevitable, or collectivism where decisions are made as a community. Myths around 
cancer, use of alternative medication, and conservatism and modesty are other socio-
cultural factors that may influence women’s health seeking behaviour. 
 
Though not as well explored, sociocultural factors like stigma may play a 
significant role in why patients are diagnosed late and why they do not complete 
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 treatment. The term ‘stigma’ has its roots in the Greek terminology describing the 
branding/tattooing that would be done to distinguish deviant individuals in the 
community. Interaction with these individuals was to be avoided. (7)  From early times, 
the notion of stigma has been associated with the labelling and isolating of individuals 
within a community. Erving Goffman in 1963 described stigma as a process through 
which an individual was perceived in a negative light by others either due to physical 
attributes, perceived character flaws or due to ethnicity. (8)  
The HIV epidemic led to an academic focus on stigma and in interventions to reduce it. 
Applying this work to cancer patients, stigma can encompass negative social attitudes 
(perceived stigma) or discriminatory behaviours (enacted stigma) where patients are 
avoided. (9) Internalized stigma or self-stigma where patients are afraid of enacted 
stigma, whether or not it has actually occurred (anticipated stigma), has also been 
described. As a result of this fear, patients isolate themselves or try to hide their diagnosis. 
(9) Stigma could also extend to the patient’s immediate family or people who have had 
contact with the patient (secondary stigma) (see. table 2.1)  
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 TABLE 2.1 TYPES OF STIGMA 
 
TYPE:  
1.Experienced 
(enacted) 
Stigma that occurs directly through interpersonal acts of 
discrimination 
2.Perceived Perception of the prevalence of stigmatizing attitudes in the 
community or among other groups e.g. healthcare providers 
 
3.Anticipated 
 
Fear of stigma whether or not it is actually experienced 
4.Secondary Stigma by association, extended to family or other caregivers of 
stigmatized individuals 
 
5. Observed  
 
Stigma occurring to others that is witnessed or heard about 
6. Layered 
 
Stigma experienced within different groups of overlapping 
populations that are marginalized/stigmatized 
 
 
Adapted from Nyblade et al (9) 
 
The socio-cultural lens also colours the way through which a particular society 
views woman with breast cancer. In a number of societies in low and middle incomes, 
there is a high social stigma associated with breast cancers. A diagnosis of cancer has 
significant implications on women and their families.  This systematic review aims to 
determine the role of stigma as a barrier to care for women with cancer in low and 
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 middle income countries, and to determine what interventions have been tried to 
mitigate stigma in this setting and to determine the effectiveness of these strategies.  
 
Materials and Methods 
Search Strategy 
A search strategy was developed with a medical librarian. The librarian then 
performed a comprehensive search of several databases. These included OVID 
Medline, OVID Embase, CINAHL, Cochrane, and PsycINFO. Subject headings and key 
words were adapted for the other databases. No restrictions on language, the 
publication date, or type of article were placed. Additional articles were incorporated by 
reviewing reference lists and forward citations of selected articles. The full search 
strategy is described below (see appendix 2). 
   
Inclusion and Exclusion Criteria 
Studies that mentioned a barrier, delay or interval in the time of treatment were 
identified. The primary outcome of interest was any study that listed stigma as a barrier 
to care or a delay in the presentation or treatment of patients. A secondary outcome 
was any study that listed interventions to mitigate stigma. These studies had to be 
performed in either low and middle income countries as defined by the World Bank 
Criteria.  Classification of the income status of the country was as per 2018 World Bank 
Criteria (10). All publications were included to reflect the breadth of publications around 
this subject. 
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 We included peer review articles that had been approved by an IRB and 
excluded abstracts, commentaries and other reviews. Studies that addressed stigma in 
patients in a low or middle income setting or any studies addressing community 
perceptions of stigma or interventions as relates to breast cancer patients were 
included. 
Figure 2.1 shows the PRISMA flow diagram that summaries the approach to study 
selection. (figure 2.1) Any molecular, genetic or any animal studies on breast cancer were 
excluded. After review of 202 full texts, 38 studies were selected for data extraction.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
41 
 
 FIGURE 2.1: PRISMA - Preferred Reporting Items for Systematic reviews and 
Metanalyses flow chart 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: PRISMA flow chart 
 
3956 References imported for 
screening 
 
  
1583 duplicates removed from 
screening 
 
2373 studies screened 
2159 studies irrelevant 
202 full text studies assessed for 
eligibility 
38 studies included 
164 studies excluded 
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 Data Process 
Studies that were identified through a database search were uploaded onto a Web-based 
systematic review software package Covidence (https://www.covidence.org/). Initially, 
abstract and title reviews of all studies were completed independently by 2 teams of 3-4 
authors. Each study had to be reviewed independently by at least two authors. Any 
differences of opinion were discussed and resolved by discussion with the two authors or 
by involving a third author when no consensus could be reached.  Full text screening was 
done by the same team and each paper had to be reviewed independently by at least two 
authors. Results were then compared across different teams. Any discrepancies were 
resolved after discussion or by incorporating a third author. In the full text review, a 
comprehensive log was maintained for studies that were excluded and the reasons 
behind exclusion were noted. (see table 2.2)  
 
TABLE 2.2: Reasons for exclusion from systematic review. 
 
                                                 164 studies excluded 
67studies -wrong 
outcomes 
Studies addressed other barriers to care but no stigma 
40 studies -  wrong design Case reports, abstracts, letters to editor 
24 studies- passing 
reference to stigma 
Mention of stigma in discussion or introduction but not in 
study results 
17 studies- No mention of 
stigma 
Studies do not address any barriers to care or stigma 
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9 studies wrong patient 
population 
Studies involving other cancers but no breast cancer 
mentioned or involving immigrant populations 
5 studies duplicated Studies appear twice in review 
2 studies -wrong setting Studies done in high income countries 
 
 
Data Extraction 
A comprehensive data extraction form was designed and tested. The data 
extraction form included the different types of stigma adapted from Nyblade and 
colleagues (9), other sociocultural factors that were mentioned alongside stigma, any 
interventions or any recommendations made to reduce stigma. Data extraction was 
performed by 2 teams of authors comprised of 3-4 authors who reviewed their work 
internally, then reviewed the studies extracted by the opposite team. Features of the 
study including the preliminary data (authors, year of publication, journal, country of 
study etc, were recorded. Specific data points were then recorded using the data 
extraction form and template. (see appendix 3). For qualitative studies emergent 
themes were identified and recorded.   
Assessment of Quality 
A detailed analysis of the quality of the studies included in the review was 
performed. Quantitative studies were evaluated using the assessment tool QUALSYST 
which provides quality criteria for studies using quantitative and qualitative methodology 
(11). Studies using quantitative methodology were assessed on 12 items including 
study design, method of subject selection, response rate, sample size, analytic 
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 methods, and whether conclusions were supported by the results (see addendum). 
This tool rates each of these as yes (2) partial (1) or no (0) or not applicable with a 
maximum score of 24 points.(appendix 4) 
For qualitative studies, we used the Consolidated Criteria for Reporting 
Qualitative Studies (COREQ), a checklist that consists of 32 criteria, which is a tool 
developed to streamline the reporting of qualitative studies. The checklist is divided in 
three domains that reflect on i) the characteristics of a research team and ii) features of 
study design including patient selection and recruitment and iii) analyses and findings 
from the study (12). (appendix 5) 
 
Data Synthesis 
Following data extraction and quality assessment a meta-synthesis was 
considered but due to the heterogeneous nature of the data, qualitative and quantitative 
studies were analyzed independently.   
 
Data analysis 
Study characteristics and overall sample characteristics were described. Stigma 
rates and sociocultural factor rates were described with binomial proportions and exact 
95% confidence intervals (CI). Differences in stigma rates and sociocultural factors by 
sample and study characteristics were assessed with Fisher's Exact test. As this 
analysis was preliminary and solely exploratory, no hypothesis test corrections were 
performed. Two-sided p-values less than 0.05 were considered statistically significant. 
All analyses were performed with SAS 9.4 (The SAS Institute, Cary, NC).  
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RESULTS 
Thirty-eight studies were selected for inclusion. These included 29 qualitative 
studies, 7 quantitative studies and 2 mixed method studies. (appendix 6) 
 
Study Characteristics 
The majority of studies were from Asia (26 studies, 68.4%) and the remainder 
from Africa (12 studies, 31.6%). Most studies were from the Middle East and South Asia 
regions (60%). Most of the publications (33 out of 38, 86.8%), were after 2010, and 
published mainly by journals in the United States (34%) or by journals in the United 
Kingdom (39.5%). The study setting was listed in most papers and was mainly urban. 
(Table 2.3).  
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 TABLE 2.3: Study characteristics 
                          
 
# Studies  38 (%) 
Year of Publication pre-2010 5  (13.2) 
2010-2014 23  (60.5) 
2014-2018 10  (26.3) 
Country of Publication United Kingdom 15  (39.5) 
United States 13  (34.2) 
Other 10  (26.3) 
Study Continent Asia 26  (68.4) 
Africa 12  (31.6) 
Study Region Middle East/South Asia 23  (60.5) 
East Asia 4  (10.5) 
South Africa 4  (10.5) 
West Africa 4  (10.5) 
East Africa 3  (7.9) 
Study Setting Available Yes 29  (76.3) 
Rural Setting Yes 11  (28.9) 
Unknown 7  (18.4) 
Semi-urban Setting Yes 2  (5.3) 
Unknown 8  (21.1) 
Urban Setting Yes 26  (68.4) 
Unknown 8  (21.1) 
Quantitative Study Methods Yes 8  (21.1) 
Qualitative Study Methods Yes 32  (84.2) 
Design Methods: 
Cross-Sectional Design Yes 7  (18.4) 
Focus Groups Yes 10  (26.3) 
Self-Administered 
Questionnaire 
Yes 3  (7.9) 
Validated Questionnaire Yes 2  (5.3) 
Unknown 1  (2.6) 
Semi-Structured Interview Yes 19  (50) 
Structured Interview Yes 6  (15.8) 
Table 3: Study characteristics. Other countries of publication include Thailand, India, Iran, Netherlands, and South Africa. 
Study settings are not mutually exclusive 
 
 
47 
 
 Study Population 
The studies had different samples with 25 studies (66%) involving breast cancer 
patients and another 17 involving either health care professionals (nurses or doctors), or 
women or men in the community or patient caregivers. (Table 2.4).  
Twenty-five studies (66%) included breast cancer patients and of these, 15 had 
stage data available (58%). The median sample size was 20 patients (range: 5-175). Of 
the studies involving breast cancer patients, 15 out of 15 studies dealt with patients with 
advanced disease (stage 3 and 4). Eight studies also dealt with patients with early 
cancers (stage 1 and 2). Non-breast cancer individuals were included in 17 of the 38 
studies (45%). Most commonly, women of the community were included (13/38, 34%) 
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Table 2.4: Study Sample 
Characteristics 
 N (%) 
Included: 
Breast Cancer Patients Yes 25  (65.8) 
Available Stage Yes 15  (57.7) 
Stage 3 Patients Yes 9  (23.7) 
Unknown 11  (28.9) 
Stage 4 Patients Yes 6  (15.8) 
Unknown 11  (28.9) 
Early Stage Patients Yes 8  (21.1) 
Unknown 11  (28.9) 
Late Stage Patients Yes 12  (31.6) 
Unknown 9  (23.7) 
Completed Treatment Patients Yes 8  (21.1) 
Breast Cancer Survivors Yes 1  (2.6) 
Total # Breast Cancer Patients Median (range) (N=26) 20 (5-175) 
Non-Breast Cancer Participants Yes 17  (44.7) 
Caregivers Yes 1  (2.6) 
Doctors Yes 1  (2.6) 
Nurses Yes 2  (5.3) 
Spouses Yes 1  (2.6) 
Men from Community Yes 2  (5.3) 
Women from Community Yes 13  (34.2) 
Total # Non-Breast Cancer 
Participants 
Median (range) (N=17) 45 (4-300) 
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 Documented treatments received by the breast cancer patients in the studies 
were surgery, chemotherapy and radiation treatment. (Table 2.5). 
Table 2. 5. Treatment 
Characteristics 
 
 N (%) 
Patients Received: 
Chemotherapy Yes 13  (34.2) 
No 2  (5.3) 
Unknown 23  (60.5) 
Radiation Yes 8  (21.1) 
No 7  (18.4) 
Unknown 23  (60.5) 
Surgery Yes 14  (36.8) 
No 3  (7.9) 
Unknown 21  (55.3) 
Treatment Delays Experienced Yes 13  (34.2) 
No 25  (65.8) 
Country has Nationalized Healthcare Yes 4  (10.5) 
No 34  (89.5) 
Country has Universal Screening Yes 6  (15.8) 
No 32  (84.2) 
 
 
 Of studies reviewed, 13 out of 38 studies listed treatment delays (38%), in the 
management of breast cancer patients. Only 4 out of the 38 studies reviewed, listed a 
nationalized health care/insurance plan in the countries of study (10.5%) and only 6 
studies mentioned available access to universal screening for breast cancer (15.8%).   
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 Types of Stigma 
The different types of stigma were recorded and examples of these different stigma types 
extracted from the text (Tables 2.6,2.7). Of the manuscripts reviewed, 37 out of 38 directly 
reported stigma (97.4%, CI 86.2-99.9%). One paper did not mention stigma directly but 
gave several examples of the different stigma types. Anticipated stigma (21/38 
studies,55.3%, CI, 38.3 -71.4%) and perceived stigma (21/38 studies,55.3%, CI 38.3 -
71.4%) were the highest reported. Layered stigma was the lowest reported (3/38 studies, 
7.9%, CI 1.7%-21.4%). Supportive quotes and statements from the literature were 
obtained. (Table 2.7, 13-18)  
 
TABLES 2.6, 2.7: STIGMA TYPES AND QUOTES: 
 
 
Stigma Type Fraction Proportion [95% CI] 
Reported 37/38 97.4% [86.2% - 99.9%] 
Anticipated 21/38 55.3% [38.3% - 71.4%] 
Experienced 11/38 28.9% [15.4% - 45.9%] 
Layered 3/38 7.9% [1.7% - 21.4%] 
Observed 4/38 10.5% [2.9% - 24.8%] 
Perceived 21/38 55.3% [38.3% - 71.4%] 
Secondary 8/38 21.1% [9.6% - 37.3%] 
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 TABLE 2.7: STIGMA QUOTES 
 
STIGMA TYPES QUOTES 
Enacted/Experienced "Family members feel that they will get the disease if they meet me. 
That is why I am alone."13  
‘‘When I got the disease, he told me, ‘You deserve it because you 
have extreme hate inside. God is punishing you’. He beat me, he hit 
me with a chair, he suffocated me, and threw me out of the home.’’14 
Anticipated 
 
….I have been crying since the diagnosis… I want to marry…breast 
cancer means that you are finished. I don’t think any man may 
accept marrying a woman with breast cancer.’14 
Perceived 
 
I cannot participate in social events. Because everyone in the 
environment considers cancer as something bad and they look at me 
differently15 
Observed 
 
“I know a young woman who had breast cancer; her husband 
married her best friend, Poor woman, her children are still young 
and can’t take care of her” 16 
 “I know a woman who had breast cancer her husband rejected her 
and married another woman because she lost her femininity” 16 
 
“I have seen when my relative suffered from BC, blood used to 
come from her breast. At that time their landlord asked them to 
leave their house as it can affect his children. Even her husband 
used to scold her and was not supportive. He was saying her it is 
better if you die.” 17 
 
Secondary  
"I am worried about my children. I came here with my husband and 
left my children alone as the village people don’t care about my 
children in case they get the same disease."13 
 
Layered ...I not only have breast cancer, but advanced breast cancer, I have 
HIV, I have no child, I have fibroids and my husband is dead...I had 
given up on life and thought I only deserved to die..so my experience 
has been a terrible one something I could not run away from, 18 
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 Sociocultural factors: 
Stigma was rarely reported in isolation and was associated with other sociocultural 
factors. These frequently had a summative effect in increasing patient delays. Thirty five 
out of thirty-eight studies, (92.1%, CI 78.6-93%), mentioned other socio-cultural factors. 
The sociocultural factors mentioned in decreasing frequency were a) fatalism (65%), b) 
myths around breast cancer (47.4%), c) fear of surgery (39.5%) d) conservatism (34.2%), 
e) use of alternative medicine (28.9%) f) spirituality/religion as a barrier (23.7%) and g) 
collectivism. Supportive quotes and statements from the literature were obtained (Tables 
2.8 and 2.9, 19-24) 
 
TABLES 2.8,2.9: Socio-cultural factors and quotes 
Sociocultural factors Fraction Proportion [95% CI] 
Any sociocultural factors reported? 35/38 92.1% [78.6%- 98.3%] 
Fatalism 24/38 65.8% [48.6%- 80.4%] 
Myths 18/38 47.4% [31.0%- 64.2%] 
Fear of Surgery 15/38 39.5% [24.0%- 56.5%] 
Conservatism 13/38 34.2% [19.6 % - 51.4%] 
Alternative Medicine 11/38 28.9% [15.4%- 45.9%] 
Religion/spirituality as barrier 9/38 23.7% [11.4%- 40.2%] 
Collectivism 2/38 5.3% [0.6%- 17.7%] 
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 TABLE 2.9: SOCIOCULTURAL QUOTES 
 
Socio-cultural factors  
Fatalism I was hopeful about life and now I don’t know about life because 
this disease is terrifying and everyone says that this disease is 
related to death. All my cousins came and started crying for me. I 
don’t even want to buy things because I am going to die. I have 
left everything..13 
 
Myths around cancer 
 
‘Cancer is contagious’ 13 
‘Cancers are due to promiscuity’19 
Some think it is contagious and if a man’s wife is inflicted with 
breast cancer, this would bring shame to him and his family34 
Conservatism 
 
. . I cannot allow another man to touch my breast . . . I would be 
accused of being adulterous if found in such a compromising 
position . . . I do not want to be divorced, which will bring disgrace 
upon my family . .20 
Fear of Mastectomy 
 
I have sacrificed my hair, I was ready to do that I am just praying 
that the sacrifice ends here and I won’t have to go on and have a 
mastectomy done. If the cancer was at stage four I will refuse 
treatment.21 
Collectivism ‘I suspected it was breast cancer when I found the lump, I told 
my husband. He refused to believe. He was in denial. I did not 
want to upset him. I listened to him. 22 
 
Most participants (n=50)* consulted a traditional healer after they 
had received a breast cancer diagnosis in a district hospital. 
Several reasons accounted for their decision to consult a 
traditional healer, namely: recommendation from their husband 
or relatives  23 
 
Alternative medicine ‘Due to a lack of knowledge, when they hear the word cancer 
they get scared, some hide it and some use traditional medicine 
until it becomes too late for treatment’23 
 
“I was really afraid of surgery, it was not wrong to try another 
treatment such as herbal medicine and another method of 
traditional treatment which were more comfortable for me”24 
 
Religion/Spirituality as a 
barrier to treatment 
 ‘I didn’t visit the local healer but always drink holy water and also 
apply emnet (holy mud) on my breast’. 23 
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 Stigma reduction: 
A number of papers proposed strategies to counter stigma. These included 
education of women and cancer advocacy (25), involvement of spiritual healers/ 
traditional healers in health promotion (20), and education of spouses (20). They also 
included using forums where women traditionally gather such as places of worship and 
women’s meetings.  
 
Associations: (supplementary material a) 
a) Continent versus stigma/sociocultural factors  
A comparison of stigma and sociocultural factor rates between the two continents 
was performed. No significant differences in stigma rates were noted between Asian 
countries and African countries (p=0.23->0.95). However, studies from Africa reported 
higher rates of alternative medicine use (58%, 7/12) compared to studies from Asia 
(15%, 4/26), p=0.017. Additionally, studies from Africa reported higher rates of myths 
(75%, 9/12) compared to Asian studies (35%, 9/26), p=0.035. No other significant 
differences were noted in sociocultural factors (p=0.16->0.95) (supplement a). 
b) Region of study versus stigma/sociocultural factors 
A further comparison of stigma and sociocultural factor proportions by region was 
performed (supplement a). Similar to the continent breakdown, no significant differences 
in stigma were noted (p=0.33->0.95), and alternative medicine rates were higher in 
other countries (60%, 9/15) compared to the Middle Eastern countries and India (9%, 
2/23), p=0.001. Additionally, fear of surgery was marginally higher in other countries 
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 (60%, 9/15) compared to Middle Eastern countries and India (26%, 6/23), p=0.049. No 
significant differences in myth rates (p=0.32) or other sociocultural factors were found 
(p=0.27->0.95). 
c) Rural settings and stigma and sociocultural factors  
A comparison of stigma and sociocultural factor rates between the rural study 
settings was done. No significant differences in stigma rates were observed between 
studies that included rural participants and those that did not (p=0.27->0.95). Similarly, 
no significant differences were found in the rates of sociocultural factors (p=0.13-0.68) 
d) Breast cancer patients and stigma type and sociocultural factors  
A comparison of stigma and sociocultural factor rates between studies that 
included breast cancer patients and those that did not was performed to see whether 
they were any unique trends between these two different populations. No significant 
differences in stigma rates were noted between these studies, although experienced 
stigma approached significance (p=0.060, others p=0.31->0.95). Studies that included 
breast cancer patients had higher rates of experienced stigma (40%, 10/25) compared 
to studies that did not include any breast cancer patients (8%, 1/13). Studies that did not 
include breast cancer patients reported higher rates of religious sociocultural factor 
(46%, 6/13) compared to studies that included breast cancer patients (12%, 3/25), 
p=0.040. No other significant differences in sociocultural factors were found (p=0.31-
>0.95). (supplement a) 
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e) Publication year and stigma, sociocultural factors.  
Comparison of stigma and sociocultural factor rates by publication year was 
performed to see if there was any increase in reports of different types of stigma. No 
significant differences were found in stigma rates (p=0.26-0.80) or sociocultural factors 
(p=0.10->0.95). (supplement a) 
f) Stigma type and sociocultural factors 
Comparison between different stigma types and sociocultural factors was done to 
see whether one could predict any clustering of sociocultural factors with a particular 
stigma type. Studies that had perceived stigma had higher rates of alternative medicine 
use (48%, 10/21) than studies that did not have perceived stigma (6%, 1/17). No other 
significant differences were found between studies that had perceived stigma and those 
that did not (p=0.21->0.95).  No significant differences were found between studies that 
had anticipated stigma and those that did not (p=0.15->0.95), and studies that had 
experienced stigma and those that did not (p=0.24->0.95). This was also true for studies 
that had layered stigma and those that did not (p=0.20->0.95) and for studies that had 
secondary stigma and those that did not (p=0.22->0.95). (supplement a) 
DISCUSSION: 
 Breast Cancer: Perceptions of self and Society forming barriers to care 
The breast is intrinsically tied in with both women’s and society’s perceptions, of 
the role of women and with sexuality and an individual’s perception of self.  Breast 
surgery for instance, is one of the surgeries associated with a very high psychological 
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 impact, as it affects women’s perception of their body image. (26) The treatment 
received for breast cancer (surgery, chemotherapy) may affect a woman’s individual 
perceptions of self, their sexuality and their child bearing capacity.  
In addition, the broader community in which a patient exists, has implications on 
how an individual perceives herself and her worth in that society. Depending on the 
social support that exists and society’s perceptions, this could potentially act as a barrier 
to access to care. In many communities in sub-Saharan Africa for instance, the role of 
women has been traditionally defined as that of child bearing and rearing (4).  The role 
of the female has been defined as a care provider and a pillar of family support. Any 
illness that compromises her ability to fulfil her family duties, may be perceived 
negatively by the community and may act as a threat to her family stability. (4) 
 
In Nigeria, a recent study showed that married women undergo a significant 
number of challenges following the diagnosis of breast cancer. In a review of 81 
patients, almost a third of women were divorced or separated (38.3%) at three years’ 
post therapy, compared to a national average of 2.6% in Nigeria. (27). In south East 
Asia women are concerned that their husband will divorce them once they have a 
breast cancer and thus delay seeking treatment for breast lumps (17). This same fear 
was echoed among women in Uganda (East Africa) (28). 
 
“So if they start thinking of cutting off the breast and what, they get scared.... mostly 
because they fear losing their families, their husbands. I look at it as that is the biggest 
problem. They shy back, stay with their lump until the lump grows until it can't be 
contained anymore. That is why they report late and it gets so obvious and they can't 
keep it anymore.”  (28) 
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 In other societies, it is taboo to talk about concerns involving reproductive 
system organs and this can delay health seeking behaviour of women (17). Some 
communities have no word for breast cancer and breast concerns are interpreted in the 
light of prevalent myths and misconceptions around cancer (23).  
 
Stigma in care 
Our results showed that stigma was prevalent in both Asian and African 
populations whether in the perception of people in the community or among health 
workers. Stigma amongst health workers was present with health workers blaming 
patients for getting the disease (25) and one study noting a higher perception of stigma 
among health workers than in the community they served, in Pakistan (29). Though 
there may be a number of reasons to explain this finding, inherent health worker biases 
could potentially impede patient care. These findings are in keeping with other studies in 
HIV where health workers would occasionally act as barriers to care (30,31, ).  
It was also interesting to note that though breast cancer patients were 
themselves stigmatized, they also stigmatized other cancer patients in certain 
situations. In a qualitative study involving both breast and cervical cancer patients, 
cervical cancer patients remarked that breast cancer patients did not want to associate 
with them as they felt that they (breast cancer patients) had a more ‘socially acceptable’ 
cause of illness than cervical cancer patients who were perceived to be 
promiscuous.(25) This might be less of individual perspectives among breast cancer 
patients, but more reflective of a broader sense of how different patients are viewed in 
that particular community. 
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 Self Stigma: Perceptions of self 
Stigma remains high in breast cancer patients who feel that they are the cause of 
shame and abuse in the community. Breast cancer patients internalize perceptions of 
the community and inadvertently perpetrate stigma by avoiding situations and places or 
by withdrawing from social interaction. 
‘I have a bad disease, and it is disgusting. My breast was cut out… it left only ugly scars 
on my chest. It looks very ugly, you see… it is a shame for women’ 24 
 
Social isolation remains high with patients feeling frequently misunderstood and unable 
to express or talk about their feelings to anyone.  
 
‘I felt that sharing stuff with others might bring disease to them. I felt it can contaminate 
my kids. Even though mor (doctor) confirmed it is not a communicable disease, it 
reminded me that I am a sick person’. 24 
 
 No one wants to talk about it, it seems as if it’s forbidden to talk about and raise’ 23 
 
Though these arbitrary divisions of the different types of stigma exist, the reality 
is a much more complex picture and interaction of several elements of stigma. Despite 
the different classifications of stigma, this is in essence a continuum with various levels 
of interphase. The reality is that one could experience, view or interpret stigma in a 
number of ways. For instance, a breast cancer patient worried about not having her 
daughters married could point perhaps to both the perceptions of breast cancer in that 
society(perceived), stigma by association (secondary) and indeed a fear of stigma that 
has not yet happened. (Anticipated)  
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 Sociocultural factors as barriers to care 
  A number of upstream determinants of health including gender equity play a key 
role in understanding the health seeking behaviour of women in many developing 
countries. The millennium development goals and subsequent sustainable development 
goals are aimed at providing equity and empowering women in societies, as an initiative 
to improve access to care for women globally (32).  
In sub -Saharan Africa for instance, women will wait an average of 11 months 
before presenting with a breast lump (4). Literacy levels had no bearing on attitude and 
knowledge around breast cancer, implying there must be other drivers for these delays 
(4). These drivers may be largely socio-cultural. A qualitative study amongst women 
who were mostly university graduates in Uganda, revealed views that women would 
rather not engage or complete their care, than have people know their diagnosis, in 
order to avoid social exclusion (28). Our findings are in keeping with reports from 
literature as we noted no significant findings existed between stigma and rural or urban 
populations, between patients or people in the community or in different regions of 
study, suggesting that stigma is a pervasive entity that permeates all sectors and strata 
of a particular community. 
In many developing countries women are not the primary determinants of their 
health seeking behaviour. In sub-Saharan Africa for instance, though women form over 
75 % of the workforce, more than 60 % are involved in subsistence farming and do not 
have a consistent income (33). They may have to rely on a partner or family for money 
to access care. (4) In addition, in many social constructs, women have to get permission 
from their spouse or family member in order to access or receive treatment (17). 
61 
 
 Women in Kenya listed spousal lack of support as a potential barrier to accessing care 
(34). Similar findings are noted in south East Asia and Arabic nations. 
 
The approach to health in many cultures in low and middle income settings may 
vary. There is frequently an aspect of ‘collectivism’ where an approach to treatment is 
not determined by the individual primarily but is decided on by the greater community. In 
addition, the decision to receive treatment was made by the community (23). Women 
from South East Asia and Ethiopia report that they were frequently asked to start 
complementary alternative medicine by their families/clan or by recommendation from a 
spouse (21). It is taboo in certain cultures for a woman to disobey the treatment 
directives given by the clan/community. This is further exacerbated by a paternalistic 
approach to medicine with patients citing that no adequate explanations to their 
treatment was provided by clinicians before initiation of care. (24)  This leads women to 
feel out of control, of their own health decisions and as such diminishes their agency as 
illustrated below. 
 
“I am a low educated person and come from a rural area; I just follow the doctor’s 
advice for my health and I do not dare to ask anything” 24 
 
 
In other instances, modesty and conservatism play a role in facilitating delays. 
Reports from Abruidis in Sudan showed that women would not seek care due to 
shyness or embarrassment over being examined by a male physician (35).  There may 
frequently be an interplay of religion and culture and reports from West Africa and the 
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 middle east show that some women believe, that it may be against their religion or 
culture, to have a male examine them (20).  It may be also regarded as taboo to expose 
certain areas of the body which should be covered up (20) .This construct could be 
further reinforced by culture. For instance, in a recent study of 50 men in the middle 
east, only 8 men would allow their wives to be examined by a male doctor, and only if it 
was a matter of life and death and not routine screening. (36). They would however be 
willing and eager to encourage their wives to participate in a breast screening program, 
if a female doctor was available. This underscores the need for culturally appropriate 
interventions. 
In many cultures, there is a pervasive element of fatalism around cancer.(13, 23) 
People believe that cancer is predestined and may be one’s fate. Since this is already 
predetermined, one should accept this and die.  Self-fulfilling myths may be sustained in 
communities where patients believe that one ‘goes to the hospital to die’. This is 
frequently the case, when patients present with advanced disease and try conventional 
medicine as a last ditch resort having exhausted alternative sources of treatment  
Recommendations for stigma reduction 
a) Education of women 
Studies suggested that education of women was key. This could involve using 
cancer advocates or community role models. They could be encouraged to get involved 
in breast cancer awareness and educational campaigns aimed at reducing social 
stigma. Suggestions included using breast cancer survivors in campaigns to change the 
narrative around breast cancer from certain death to survival (25).  
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 Community events such as meetings and other gatherings were identified as 
appropriate places for promoting health education, as the majority of community 
members attend these gatherings. Additionally, it was suggested that health personnel 
organize special education programs for women. (21) Studies suggested that women’s 
groups in the district can also be utilized as a cancer aware-ness campaign tool. The 
formation of women social groups is a key feature in small communities and these could 
be targeted. 
b) Involvement of spiritual healers/traditional healers.   
Many patients attach a spiritual etiology to their cancer. As a result, a number of 
individuals will seek out traditional or spiritual healers to address or treat the cancer. 
Patients suggested including these healers (20) in the care management plans or 
educating them so as to enhance patient engagement and retention in conventional 
medical treatment.  
c) Education of spouse/partners 
Education of partners was suggested in a number of studies as a way of 
reducing stigma. Getting partners to accept their partners, post diagnosis was 
suggested as a way to address the perceived stigma around breast patients. As many 
populations attributed breast cancer to promiscuous or dubious behavior like being 
involved in witchcraft, it would be important to educate partners and the broader 
community to accept cancer patients. In addition, if women were less worried about 
losing their marriages and families, they are likely to present earlier.  
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 However, it is important to note that different socio-cultural factors may come 
into play when suggesting different strategies. For instance, women stated they found 
listening to breast cancer survivor stories as not helpful and distressing, especially if 
survivors shared negative experience, as illustrated below. 
 ‘‘I knew one and we became friends, then she started to complain, I have back pain, so 
I started to have the same complaints, so I stopped sitting next to her”14 
 
Limitations: 
Due to small number of studies derived it is difficult to draw any broad 
conclusions. In addition, due the predominantly qualitative nature of the studies 
involved, it would be difficult to generalize this to multiple populations. However, we 
noted that regardless of the region, stigma around breast cancer was prevalent and 
though assigned different aetiologies or causes, the end result was ostracization of the 
individual with often resultant significant psychological distress. None of the studies 
reviewed discussed any interventions aimed specifically at reducing stigma highlighting 
a gap that requires urgent intervention. 
 
Conclusion: 
 
Stigma in breast cancer continues to be prevalent in different populations across 
low and middle incomes globally. Urgent interventions are required as part of a multi-
level plan to curb advanced disease at diagnosis of breast cancer and treatment 
discontinuations seen.  These interventions will require an in depth understanding of the 
socio-cultural factors at play in that particular environment.   
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 APPENDIX 1: 
 
INTERVIEWERS/MODERATOR GUIDE –BREAST CANCER 
Introductory questions. What year were you first diagnosed with breast cancer? How 
many years have you lived with breast cancer? 
Transition question. Tell me about the treatment you received when you were 
diagnosed with breast cancer to date. How long did it take? Any delays? 
Key questions: 
1.What helped you go through the treatment once you received your diagnosis? 
2.What did you find challenging?Were you able to overcome these challenges? 
Probe-How were you able to do this? Could you give me some examples? 
3. Looking back over your treatment/cancer journey, what emotions come to 
mind?Tell me a little more about this.  
Probe: Why did that emotion come to mind? Do you have instances that you remember 
4. Are there people in your life who help you when you are in need of something? 
How do these people help? Are there people who make it difficult for you to obtain 
what you needed? How did they do this? 
Probes-Are you married/have a partner? What do they think about your breast cancer? 
-What do your family/friends say about your breast cancer? (do they know your 
diagnosis? ) 
-Are you working? What do your co-workers/boss say? 
5. Tell me about your relationship with the doctors/medical staff treating your 
breast cancer? 
Probes: - What things could affect the treatment people receive from medical staff or 
doctors? 
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 -What do you understand about seeing your doctor/oncologist. Is there a regular doctor 
you see? 
-Are there any organisations or institutions that support you with this? 
 
6. Are you on any medication for your cancer? What is the experience with this? 
Probes-any new effects? Are you taking it regularly? Is it accessible/available always? 
7. Some people say that people who get cancer may have done something to cause 
it? What would you tell them? 
Comment: This is a question designed to interrogate/determine beliefs around breast 
cancer. An initial study showed a high prevalence of myths around breast cancer. 
Closing 
So you said (patients words) ……..makes it easier/difficult to get the healthcare you 
require?  
Is there anything else you would like to share with me about your cancer experience? 
What could be done to make it easier for you and other ladies to go through treatment 
and receive care now? 
 
Thank you so much for your time and for sharing with us this important information. 
Approach to the summary 
This closes the loop of the discussion and helps to clarify the themes discussed. It is also 
an opportunity to explore any unmentioned areas and views that the patient has. 
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 Appendix 2: 
Systematic review search strategy 
WEILL CORNELL SEARCH STRATEGY 
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 Original Request 
 
Qualtrics Submission for Systematic Review at 03/15/17 3:15 PM 
 
----------------------------------------------------------------------- 
Response Summary:  
Name:  
   Miriam Mutebi  
CWID:  
   mim2072@med.cornell.edu  
Institution:  
   Weill Cornell Medical College  
Department:  
   Medicine  
Phone:  
   6466441726  
Email:  
   Mim2072@med.cornell.edu  
Status:  
   Fellow/Resident  
Proposed title:  
   Women and cancer: understanding barriers and facilitators to the diagnosis, treatment and follow up 
of breast and gynecological cancers in low and middle income countries  
Timeframe for completion for search:(Generally searches for published and unpublished studies average 
three to eight months)  
   11/01/2017  
Intended systematic review submission date:  
   02/12/2018  
Type of project:  
   Course research project  
What is the aim of this systematic review?  
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    To understand the barriers to the management of breast and gynecological cancers in developing 
countries where patients typically present with advanced disease and to explore 
strategies/interventions that exist that mitigate these barriers.  
Please list the members of your systematic review team and their role (Name, Role, Email):  
   1.Miriam mutebi -PI - mim2072@med.cornell.edu / mcmutebi@yahoo.com  
   2. Dr Andrea Pusic - pusica@mskcc.org - mentor  
   3. Dr Peter Kingham- kinghamt@mskcc.org- mentor  
   4. Dr Asad Raja- asad.raja@aku.edu- mentor 
 5. Dr Marleen Temmerman- Marleen.temmerman@aku.edu -mentor  
Patients, population or problem: (Important characteristics including disease/condition, age, gender, 
race/ethnicity)  
   Women with breast cancers in developing countries (Africa)  
Intervention: (Drug/treatment; diagnostic test/screening test; exposure; prognostic factor/risk 
factors/lifestyle)  
   Management I.e. Diagnosis, treatment, follow up  
   Barriers to management  
   Facilitators to management  
Outcome: (What to measure - improvement in health; prevention of illness; adverse events; accuracy)  
   Delay in diagnosis, delay in treatment,  
   Mortality, premature deaths  
Please restate your question using components of PICO:  
   To determine stigma as a barrier to management of women with breast cancer in low and middle 
income countries  
Relevant terms: (Please list significant words, phrases, and acronyms)  
   Breast neoplasms   
   Barriers to care  
   Access to care  
   Delays  
   Diagnosis  
   Treatment  
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    Follow up  
   Stigma  
   LMICs  
   Sub Saharan Africa  
Relevant databases: (Please list relevant resources that should be searched. Note that the librarian may 
also offer recommendations)  
   Pub Med  
   Medscape  
   Google scholar  
   African journals online  
Gender:  
   Female  
Age range (select all that apply):  
   Adult: 19-44 years  
   Middle Aged: 45-64 years  
   Middle Aged and Aged: 45+ years  
   Elderly: 65+ years  
Languages:  
   English and foreign language articles with English abstracts  
Publication years:  
   Current year + 10  
Humans only studies:  
   Yes  
What kind of study designs should be captured by the search?  (select all that apply)  
   Randomized controlled trials  
   Controlled trials  
   Cohort studies  
   Case control studies  
   Case series  
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 Which of the following publication types are appropriate?  (select all that apply)  
   Research articles in journals  
   Comment, editorial, letter  
   Books/book chapters  
   Conference proceedings/meeting abstracts  
   Dissertations/theses  
   Research in progress  
How many results do you expect to find on this topic?  
   100-200  
How many citations are you willing to review?  
   800-1000  
Have you already identified any relevant articles or authors? Please include citation or PMID: (Please 
also include the names of any resources you have already searched)  
   Systematic review of barriers to breast cancer care in developing countries resulting in delayed patient 
presentation Sharma K, CostasA, Shulman LN, Meara JG  
   PMID:22956949 pubmed  
Should auto-alerts be generated? (Auto Alerts are a personalized current awareness service via email. 
Databases searches are run at selected time intervals, obtaining the most recent additions to the 
database that fit your search parameters)  
   Yes  
How do you want the results delivered?  
   Excel  
Additional comments:  
   An initial pub Med search revealed about 100 articles however there may be a need to have search 
engines that list more African studies like African Index Medicus etc. I limited the search to articles that 
are written in English or have a translation for ease of data extraction  
In the interests of producing the most valid search strategy, may we ask for outside review?(In 
accordance with IOM standard 3.1.3 for Systematic Reviews, I agree to allow “an independent librarian 
or other information specialist to peer review the search strategy” developed by a WCMC Librarian)    
   Yes 
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 Librarian Timeline and Feedback 
LIBRARIAN ROLE IN THE SYSTEMATIC REVIEW (SR) COLLABORATION INCLUDES 
 
• Translating the research question into an appropriate search strategy for each 
database. 
• Translating the concepts into controlled vocabulary and keywords so that retrieval is 
maximized at the same time as being precise. 
• Recommending pre-existing filters. 
• Recommending specific databases and other information sources to be searched. 
• Conducting the literature searches. 
• Delivering the results using a bibliographic management tool. 
• Running search updates in selected databases (as needed). 
• Recommending journals for publication based upon manuscript subject area, impact 
factors and journal submission guidelines. 
• Once the SR is completed, the librarian writes the literature search methodology 
section for the submitted manuscript, maintains records of search results, and 
follows up with alerts and updates as needed. 
• Librarians are co-authors on SR collaborations. 
ESTIMATED TIMELINE (8-16 WEEKS) 
 
1. Conduct a preliminary search in Ovid’s Medline deliver the strategy and results to the 
team for review (2 Weeks) 
 
2. The team will inform us if there are concepts/terms that might have been overlooked 
that should be included and/or if the results appear on target. If this search is OK, we 
will move ahead to the additional databases. We will also deliver the strategy to an 
EXTERNAL librarian for review and feedback.  (1 week) 
 
3. Search teams propose relevant databases and Librarians may suggest others. Librarians 
search recommended databases (8 Weeks -10 weeks) 
LIBRARIAN PRELIMINARY DATABASE RECOMMENDATIONS: 
1. Medline 
2. EMBASE 
3. Cochrane Library 
4. CINAHL 
5. PsycINFO 
 
4. Deliver results via Covidence 
There will probably be a lot of overlap. The Librarian will remove duplicate records and 
coordinate the EndNote database. 
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 5. Cited and Reference Search -Time frame varies depending on number of articles 
chosen (2+ weeks) 
The team will select the articles for inclusion and send to the Librarians. Using Scopus 
and/or Web of Science the librarians will conduct a search of the references listed in the 
bibliographies and an additional search to determine if the inclusion articles have been 
cited. Deliver results via EndNote. 
6. Related articles Search (1 week) 
A related articles search in PubMed will be conducted based on the inclusion articles. 
Deliver results via EndNote. 
7. Write literature search methodology (1 week, could be much shorter) 
Once the literature search is completed we will write the literature search methodology 
section for the submitted manuscript 
8. Follow up with alerts and updates (if needed) (Ongoing/until submission to publication)  
 
9. Suggest Journals for manuscript submission (optional) (2 days) 
Suggestions will include a report with instructions to authors, Impact Factors and indexing 
information.  
Databases Searches and Number of Results 
Database Dates searched Number of 
references 
retrieved 
Total 
number 
after de-
duplication 
Ovid MEDLINE(R) In-Process & Other 
Non-Indexed Citations and Ovid 
MEDLINE(R) 1946 to Present 
01/25/18 1314  
Embase (Ovid) 1974 to Present 01/25/18 1202  
Cochrane Reviews, part of The 
Cochrane Library. 
01/25/18 79  
CINAHL 01/25/18 268  
PsycINFO 01/25/18 463  
Sub-total   3326  
PubMed - related articles and Scopus 
– forward citations 
 626  
Total after combining and deleting 
duplicates from subject and related 
 3956 2373 
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articles, cited reference & reference 
& cited reference & reference 
 
Database Search Strategies 
OVID MEDLINE(R) IN-PROCESS & OTHER NON-INDEXED CITATIONS AND OVID 
MEDLINE(R) 1946 TO PRESENT – JANUARY 25, 2018 
 
1. exp Breast Neoplasms/   
2. ((breast or mamma*) adj2 (cancer* or neoplasm* or tumor* or tumour* or mass*)).mp. 
[mp=title, abstract, original title, name of substance word, subject heading word, keyword 
heading word, protocol supplementary concept word, rare disease supplementary concept 
word, unique identifier, synonyms]   
3. exp Developing Countries/  
4. ((develop* adj2 (countr* or area*)) or (low* adj1 resource*) or (third adj1 world adj1 
countr*)).mp. [mp=title, abstract, original title, name of substance word, subject heading word, 
keyword heading word, protocol supplementary concept word, rare disease supplementary 
concept word, unique identifier, synonyms]   
5. exp Africa, Southern/ or exp Africa, Northern/ or exp Africa, Central/ or exp Africa/ or exp 
Africa, Western/ or exp Africa, Eastern/   
6. exp Middle East/   
7. exp Asia, Southeastern/ or exp Asia, Northern/ or exp Asia/ or exp Asia, Central/ or exp Asia, 
Western/   
8. (Afghani* or Armenia* or Bangladesh* or Benin or Bhutan or Bolivia* or "Burkina Faso" or 
Burundi or "Cabo Verde" or Cambodia* or Cameroon or "Central African Republic" or Chad or 
Comoros or Congo or "Cote d'Ivoire" or Djibouti or Egypt* or "El Salvador" or Eritrea or 
Ethiopia* or Gambia or Ghana or Guatemala or Guinea or Haiti* or Hondura* or India* or 
Indonesia* or Kenya* or Kiribati or "North Korea" or Kosovo or Kyrgyz or Lesotho or Liberia* or 
Madagascar or Malawi or Mali or Mauritania or Micronesia or Moldova or Mongolia* or 
Morocco or Mozambique or Myanmar or Nepal* or Nicaragua* or Niger* or Pakistan* or 
"Papua New Guinea" or Philippin* or Rwanda or Samoa or Senegal or "Sierra Leone" or 
"Solomon Islands" or Somalia* or "South Sudan" or "Sri Lanka" or Sudan or Swaziland or Syria* 
or Tajikistan or Tanzania or Togo or Tonga or Tunisia* or Uganda* or Ukrain* or Uzbekistan or 
Vanuatu or Vietnam or Yemen or Zambia or Zimbabwe).mp. [mp=title, abstract, original title, 
name of substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, unique identifier, 
synonyms]   
9. exp Health Knowledge, Attitudes, Practice/   
10. exp Social Stigma/   
11. exp "Patient Acceptance of Health Care"/   
12. (stigma* or (health adj1 (attitude* or knowledg*))).mp. [mp=title, abstract, original title, 
name of substance word, subject heading word, keyword heading word, protocol 
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 supplementary concept word, rare disease supplementary concept word, unique identifier, 
synonyms]   
13. 1 or 2   
14. 3 or 4 or 5 or 6 or 7 or 8   
15. 9 or 10 or 11 or 12   
16. 13 and 14 and 15 
THE COCHRANE LIBRARY WILEY - JANUARY 25, 2018 
 
#1 MeSH descriptor: [Breast Neoplasms] explode all trees 
#2 ((breast or mamma*) near/2 (cancer* or neoplasm* or tumor* or tumour* or mass*))  
#3 MeSH descriptor: [Developing Countries] explode all trees 
#4 ((develop* near/2 (countr* or area*)) or (low* near/1 resource*) or (third near/1 world 
near/1 countr*))  
#5 MeSH descriptor: [Africa] explode all trees 
#6 MeSH descriptor: [Middle East] explode all trees 
#7 MeSH descriptor: [Asia] explode all trees 
#8 (Afghani* or Armenia* or Bangladesh* or Benin or Bhutan or Bolivia* or "Burkina Faso" 
or Burundi or "Cabo Verde" or Cambodia* or Cameroon or "Central African Republic" or Chad 
or Comoros or Congo or "Cote d'Ivoire" or Djibouti or Egypt* or "El Salvador" or Eritrea or 
Ethiopia* or Gambia or Ghana or Guatemala or Guinea or Haiti* or Hondura* or India* or 
Indonesia* or Kenya* or Kiribati or "North Korea" or Kosovo or Kyrgyz or Lesotho or Liberia* or 
Madagascar or Malawi or Mali or Mauritania or Micronesia or Moldova or Mongolia* or 
Morocco or Mozambique or Myanmar or Nepal* or Nicaragua* or Niger* or Pakistan* or 
"Papua New Guinea" or Philippin* or Rwanda or Samoa or Senegal or "Sierra Leone" or 
"Solomon Islands" or Somalia* or "South Sudan" or "Sri Lanka" or Sudan or Swaziland or Syria* 
or Tajikistan or Tanzania or Togo or Tonga or Tunisia* or Uganda* or Ukrain* or Uzbekistan or 
Vanuatu or Vietnam or Yemen or Zambia or Zimbabwe)  
#9 MeSH descriptor: [Health Knowledge, Attitudes, Practice] explode all trees 
#10 MeSH descriptor: [Social Stigma] explode all trees 
#11 MeSH descriptor: [Patient Acceptance of Health Care] explode all trees 
#12 (stigma* or (health near/1 (attitude* or knowledg*)))  
#13 #1 or #2  
#14 #3 or #4 or #5 or #6 or #7 or #8  
#15 #9 or #10 or #11 or #12  
#16 #13 and #14 and #15 
EMBASE (OVID) 1974 TO JANUARY 31, 2014- JANUARY 25, 2018 
 
1. exp breast tumor/   
2. ((breast or mamma*) adj2 (cancer* or neoplasm* or tumor* or tumour* or mass*)).mp. 
[mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug 
manufacturer, device trade name, keyword, floating subheading word]   
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 3. exp developing country/   
4. ((develop* adj2 (countr* or area*)) or (low* adj1 resource*) or (third adj1 world adj1 
countr*)).mp. [mp=title, abstract, heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword, floating subheading word]   
5. exp "Africa south of the Sahara"/ or exp South Africa/ or exp Africa/ or exp North Africa/ or 
exp Central Africa/   
6. exp Middle East/   
7. exp South Asia/ or exp Asia/ or exp Southeast Asia/   
8. (Afghani* or Armenia* or Bangladesh* or Benin or Bhutan or Bolivia* or "Burkina Faso" or 
Burundi or "Cabo Verde" or Cambodia* or Cameroon or "Central African Republic" or Chad or 
Comoros or Congo or "Cote d'Ivoire" or Djibouti or Egypt* or "El Salvador" or Eritrea or 
Ethiopia* or Gambia or Ghana or Guatemala or Guinea or Haiti* or Hondura* or India* or 
Indonesia* or Kenya* or Kiribati or "North Korea" or Kosovo or Kyrgyz or Lesotho or Liberia* or 
Madagascar or Malawi or Mali or Mauritania or Micronesia or Moldova or Mongolia* or 
Morocco or Mozambique or Myanmar or Nepal* or Nicaragua* or Niger* or Pakistan* or 
"Papua New Guinea" or Philippin* or Rwanda or Samoa or Senegal or "Sierra Leone" or 
"Solomon Islands" or Somalia* or "South Sudan" or "Sri Lanka" or Sudan or Swaziland or Syria* 
or Tajikistan or Tanzania or Togo or Tonga or Tunisia* or Uganda* or Ukrain* or Uzbekistan or 
Vanuatu or Vietnam or Yemen or Zambia or Zimbabwe).mp. [mp=title, abstract, heading word, 
drug trade name, original title, device manufacturer, drug manufacturer, device trade name, 
keyword, floating subheading word]   
9. exp attitude to health/   
10. exp social stigma/  
11. exp patient attitude/   
12. (stigma* or (health adj2 (attitude* or knowledg*))).mp. [mp=title, abstract, heading word, 
drug trade name, original title, device manufacturer, drug manufacturer, device trade name, 
keyword, floating subheading word]   
13. 1 or 2   
14. 3 or 4 or 5 or 6 or 7 or 8   
15. 9 or 10 or 11 or 12   
16. 13 and 14 and 15 
 
CINAHL - JANUARY 25, 2018 
 
S14 S11 AND S12 AND S13   
S13 S9 OR S10   
S12 S3 OR S4 OR S5 OR S6 OR S7 OR S8   
S11 S1 OR S2   
S10 (stigma* or (health N1 (attitude* or knowledg*)))   
S9 (MH "Stigma")   
S8 (Afghani* or Armenia* or Bangladesh* or Benin or Bhutan or Bolivia* or "Burkina Faso" 
or Burundi or "Cabo Verde" or Cambodia* or Cameroon or "Central African Republic" or Chad 
or Comoros or Congo or "Cote d'Ivoire" or Djibouti or Egypt* or "El Salvador" or Eritrea or 
82 
 
 Ethiopia* or Gambia or Ghana or Guatemala or Guinea or Haiti* or Hondura* or India* or 
Indonesia* or Kenya* or Kiribati or "North Korea" or Kosovo or Kyrgyz or Lesotho or Liberia* 
or Madagascar or Malawi or Mali or Mauritania or Mic ...  
S7 (MH "Asia+") OR (MH "Asia, Western+") OR (MH "Asia, Southeastern+") OR (MH "Asia, 
Central+")   
S6 (MH "Middle East+")   
S5 (MH "Africa+") OR (MH "Africa South of the Sahara+") OR (MH "Africa, Western+") OR 
(MH "Africa, Southern+") OR (MH "Africa, Northern+") OR (MH "Africa, Eastern+") OR (MH 
"Africa, Central+")   
S4 ((develop* N2 (countr* or area*)) or (low* N1 resource*) or (third N1 world N1 
countr*))   
S3 (MH "Developing Countries")   
S2 ((breast or mamma*) N2 (cancer* or neoplasm* or tumor* or tumour* or mass*))   
S1 (MH "Breast Neoplasms+") 
 
PSYCINFO - JANUARY 25, 2018 
 
S9 S1 AND S7 AND S8   
S8 S2 OR S3 OR S4 OR S5 OR S6   
S7 (stigma* or (health N1 (attitude* or knowledg*)))   
S6 (Afghani* or Armenia* or Bangladesh* or Benin or Bhutan or Bolivia* or "Burkina Faso" 
or Burundi or "Cabo Verde" or Cambodia* or Cameroon or "Central African Republic" or Chad 
or Comoros or Congo or "Cote d'Ivoire" or Djibouti or Egypt* or "El Salvador" or Eritrea or 
Ethiopia* or Gambia or Ghana or Guatemala or Guinea or Haiti* or Hondura* or India* or 
Indonesia* or Kenya* or Kiribati or "North Korea" or Kosovo or Kyrgyz or Lesotho or Liberia* or 
Madagascar or Malawi or Mali or Mauritania or Mic ...  
S5 Asia*   
S4 "Middle East"   
S3 Africa*   
S2 ((develop* N2 (countr* or area*)) or (low* N1 resource*) or (third N1 world N1 
countr*))   
S1 ((breast or mamma*) N2 (cancer* or neoplasm* or tumor* or tumour* or mass*)) 
 
 
 
 
Appendix 3: Data extraction sheet 
Variable Responses 
Reviewer  
Title Free text 
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 Unique Identifier 
(UI)/PMID Number 
Free text 
Year of Publication  
Country of Publication  
Journal  
Open Access Journal Yes/no 
Accept /reject 
Inclusion criteria – 
addresses: 
         Stigma 
-  Treatment delays 
- Barriers 
- Interventions 
Accept /Review/Discuss with co-reviewers 
If ‘Reject’ or ‘Discuss’, 
please note reasons why 
Free text 
Introduction:  
Country  
 
Free text 
Continent Asia/Africa/North America/Europe/South America/ Australia/Antartica 
Region South East Asia/East Asia/Central Asia/South West Asia (Middle 
East)/ West Africa/East Africa/South Africa/North Africa/Central 
America/South America/Carribean/North Africa 
Breast Cancer 
 
Yes/no 
Other cancer Yes /no 
List other Type of cancer Free text 
Author i.e. Raza et al, (for 
authors with multiple 
papers list first and 
second authors i.e. 
Bannon, hanning et al)  
Free text 
Study type Qualitative/Quantitative/Mixed methods 
Qualitative Study 
design/instruments 
Structured Interview / Semi- structured interview/ Focus 
groups/Community meetings/Cross-sectional study /  
Quantitative Study 
design/instruments –Tick 
all that apply 
Cross sectional survey 
Self-designed questionnaire/ Validated questionnaire 
Multiple samples Yes/No 
Sample Population and 
size 
1.Breast cancer patients 
with early disease 
2. breast cancer patients 
with advanced disease 
3. Breast cancer survivors 
4. Women attending clinic  
5. Women in the 
community 
6. Men in the community 
7. Spouses of breast 
cancer patients 
8. Caregivers of breast 
cancer patients(relatives) 
9.Nurses  
10.Doctors 
Indicate numbers of each sample population: Free text 
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 11. Others -specify 
Range of population ages 
(indicate if not given) 
Free text 
Mean of population age 
(indicate if not given) 
Free text 
Population characteristics 
Indicate distribution in 
Sample population 
Married ----, Single…….Divorced……Widowed…. 
 
No of children (means if 
listed) 
Free text 
Study setting Urban/ rural/ Semi-urban/unknown 
Stage of cancer of 
participants mentioned 
Yes/No/Mentioned 
If listed numbers and 
percentages of patients 
with stage 3 and 4 
Free text 
Treatment listed Yes/No/Not mentioned 
Treatments given to 
population 
Surgery/Chemotherapy/Radiation Therapy 
Sample population 
completed treatment 
Yes/ No/Not mentioned 
Country has national 
insurance scheme 
Yes/No/Not mentioned 
Population has access to 
screening for breast 
cancer 
Yes/no/Not mentioned 
Distance from health 
facility given 
Yes/no/not mentioned (explain if given) 
Are any delays 
defined/reported? 
Yes / no / unsure____ 
What was the primary 
outcome measure and 
what were the results? 
Free text 
Barriers  
Stigma reported? Yes/no/unsure___ 
Type of stigma 1. Experienced (stigma that is enacted through interpersonal 
acts of discrimination) 
2. Perceived (perception of the prevalence of stigmatizing 
attitudes in the community or among other groups( e.g health 
care providers) 
3. Anticipated (Fear of stigma whether or not it is actually 
experienced) 
4. Secondary (sigma by association, extended to family or other 
care givers of stigmatized individuals) 
5. Observed (stigma occurring to others that is witnessed or 
observed) 
6. Layered (the intersecting of stigmas faced by individuals who 
are part of multiple marginalized groups) 
Qualitative 
findings/Themes 
Free Text 
Other barriers reported Yes/no/unsure 
Type of barriers reported 1. Financial factors – No money to pay for treatment 
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 (tick all that apply) 2. Logistical ( no time to access health care/ no one to take the 
to hospital for treatment/looking after others) 
3. Poor cancer awareness (Lack of knowledge of breast cancer 
and risk factors) 
4. Poor access to diagnostics 
5. Inaccurate clinical assessment misdiagnosis 
6. poor referral pathways 
7. Geographical barriers  
8. Sociocultural factors 
9. Other…….explain 
Other social cultural 
factors 
Yes/no/unsure 
If yes for socio-cultural 
reasons. Tick all that apply 
1. Fatalism (belief that death is inevitable for all cancer patients 
so why seek treatment) 
2. Conservatism/modesty (Shy/embarrassed to be examined by 
anyone male) 
3. Collectivism (decisions made as a community not as an 
individual) 
4. Use of complementary alternative medicine 
5. Fear of Surgery/Mastectomy 
6. Myths/beliefs around cancer – e.g. caused by evil eye 
7. Religious beliefs as a barrier 
 
Interventions  
Any interventions to 
decrease stigma 
addressed? 
Yes / no / unsure___ 
Which intervention(s) 
reported 
Community engagement/Improving health literacy/Improving access 
to primary care 
Improving primary care provider capacity/educating health 
workers/Providing supportive counselling and care 
Increasing availability of treatment/Addressing financial 
issues/Improving communication and engagement 
Was intervention reported 
as successful/efficacious 
Yes / no / not studied or reported 
What outcome measure 
was used to report the 
intervention success? 
Time interval / stage of disease / treatment access / other 
 
Duration of interval: (decrease in days) 
Stage of disease: (decrease in advanced stage) 
Treatment access: (number of cancer patients accessing care) 
Other: () 
Were recommendations 
given  
Yes/ no/unsure 
What recommendations 
given 
Free text 
Quality assessment  
Rate study in terms of  
bias- Qualsyst, COREQ 
N/A or yes (2)  Partial (1) or No (1) 
Justify reason Free text 
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Appendix 4: 
QualSyst scoring criteria for assessing study quality of studies: 
Checklist for assessing the quality of quantitative studies 
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 Criteria 
 
1. Question / objective sufficiently described? 
 
2.  Study design evident and appropriate? 
 
3. Method of subject/comparison group selection or source of 
information/input variables described and appropriate? 
 
4. Subject (and comparison group, if applicable) characteristics 
sufficiently described? 
 
5. If interventional and random allocation was possible, was it 
described? 
 
6. If interventional and blinding of investigators was possible, was it 
reported? 
 
7. If interventional and blinding of subjects was possible, was it 
reported? 
 
8. Outcome and (if applicable) exposure measure(s) well defined 
and robust to measurement / misclassification bias? means of 
assessment reported? 
 
9 Sample size appropriate? 
 
10. Analytic methods described/justified and appropriate? 
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 11. Some estimate of variance is reported for the main results? 
 
12. Controlled for confounding? 
 
13. Results reported in sufficient detail? 
 
14. Conclusions supported by the results? 
 
 
 
Scoring: YES (2) PARTIAL(1) NO(0) N/A  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 5: COREQ method for scoring 
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COREQ 32 item scoring system. 
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APPENDIX 6: 
 SUMMARY OF REVIEW STUDIES 
 
 Author Study Title Study Type Year of 
Publication 
Publisher 
1 
 
 
Al Dasoqi et al. Screening for breast cancer 
among young Jordanian 
women: ambiguity and 
apprehension. 
Qualitative 2013 International 
Nursing Review 
2 Alqaissi, N.M. et 
al. 
Exploring common meanings of 
social support as experienced 
by Jordanian women with 
breast cancer. 
Qualitative 2010 Cancer Nursing 
3 Asobayire, A et al. Women's cultural perceptions 
and attitudes towards breast 
cancer: Northern Ghana. 
Qualitative 2015 Health 
Promotion 
International 
4 Aziato, L et al. Breast Cancer Diagnosis and 
Factors Influencing Treatment 
Decisions in Ghana. 
Qualitative 2015 Health Care for 
Women 
International 
 
5 Banning M et al. Perceptions of breast health 
practices in Pakistani Muslim 
women. 
Mixed 
Methods 
2009 Asian Pacific 
Journal of 
Cancer 
Prevention 
6 Banning, M et al. Managing the illness 
experience of women with 
advanced breast cancer: hopes 
and fears of cancer-related 
insecurity. 
Qualitative 2013 European 
Journal of 
Cancer Care 
7 Banning, M et al. The impact of culture and 
sociological and psychological 
issues on Muslim patients with 
breast cancer in Pakistan. 
Qualitative 2009 Cancer Nursing 
8 De Ver Dye, T et 
al. 
A mixed-method assessment of 
beliefs and practice around 
breast cancer in Ethiopia: 
implications for public health 
programming and cancer 
control. 
Mixed 
Methods 
2011 Global Public 
Health 
 
 
 
9 
Dey, S et al. Breast Cancer Awareness and 
Prevention Behavior Among 
Women of Delhi, India: 
Identifying Barriers to Early 
Detection. 
Qualitative 2016 Breast Cancer: 
Basic and 
Clinical 
Research 
10 Doumit, M.A.A. et 
al. 
 
Living with breast cancer, a 
Lebanese experience. 
Qualitative 
 
2010 European 
Journal of 
Oncology 
Nursing : The 
Official Journal 
of European 
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Oncology 
Nursing Society 
11 Gunusen N.P. et 
al. 
Experiences of Turkish women 
with breast cancer during the 
treatment process and 
facilitating coping factors. 
Qualitative 2013 Asian Pacific 
Journal of 
Cancer 
Prevention 
12 Iskandarsyah, A 
et al. 
Psychosocial and cultural 
reasons for delay in seeking 
help and nonadherence to 
treatment in Indonesian women 
with breast cancer: a qualitative 
study. 
Qualitative 2014 Health 
psychology: 
Official Journal 
of the Division of 
Health 
Psychology, 
American 
Psychological 
Association 
13 Keshavarz, Z et 
al. 
Factors for performing breast 
and cervix cancer screening by 
Iranian female workers: a 
qualitative-model study. 
Qualitative 2011 Asian Pacific 
Journal of 
Cancer 
Prevention 
14 Khazaee-Pool, M 
et al. 
 
Breast cancer-preventive 
behaviors: exploring Iranian 
women's experiences. 
Qualitative 
 
2014 BMC Women's 
Health 
15 Lim, J.N.W. et al. 
 
Barriers to early presentation of 
self-discovered breast cancer in 
Singapore and Malaysia: a 
qualitative multicentre study. 
Qualitative 
 
2015 BMJ Open 
16 Maree J.E. et al. "My experience has been a 
terrible one, something I could 
not run away from": Zambian 
women's experiences of 
advanced breast cancer. 
Qualitative 2015 International 
Journal of Africa 
Nursing 
Sciences 
17 McEwan, J et al. "Injustice! That is the cause": a 
qualitative study of the social, 
economic, and structural 
determinants of late diagnosis 
and treatment of breast cancer 
in Egypt. 
Qualitative 2014 Cancer Nursing 
18 Mdondolo N et al. Cultural factors associated with 
the management of breast 
lumps amongst Xhosa women. 
Qualitative 2003 Health SA 
Gesondheid 
Sep 
19 Meacham, E et al. Exploring stigma as a barrier to 
cancer service engagement 
with breast cancer survivors in 
Kampala, Uganda. 
Qualitative 2016 Psycho-
oncology 
20 Mena, M et al. Evaluation of the impact of a 
breast cancer awareness 
program in rural Ghana: a 
cross-sectional survey. 
Quantitative 2014 International 
Journal of 
Cancer 
21 Najmabadi, K.M. 
et al. 
Self-disclosure of breast cancer 
diagnosis by Iranian women to 
friends and colleagues. 
Quantitative 2014 Asian Pacific 
Journal of 
Cancer 
Prevention 
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22 Nyblade, L et al. A qualitative exploration of 
cervical and breast cancer 
stigma in Karnataka, India. 
Qualitative 2017 BMC Women's 
Health 
23 Obeidat, R.F. et 
al. 
Controlling fear: Jordanian 
women's perceptions of the 
diagnosis and surgical 
treatment of early stage breast 
cancer. 
Qualitative 2012 Cancer Nursing 
24 Ohaeri, B.M. et al. Relationship of knowledge of 
psychosocial issues about 
cancer with psychic distress 
and adjustment among breast 
cancer clinic attendees in a 
Nigerian teaching hospital. 
Quantitative 2012 Psycho-
oncology 
25 Ohaeri, J.U. et al. Psychosocial concerns of 
Nigerian women with breast 
and cervical cancer. 
Quantitative 1998 Psycho-
oncology 
26 Opoku, S.Y. et al. Knowledge, attitudes, beliefs, 
behaviour and breast cancer 
screening practices in Ghana, 
West Africa. 
Quantitative 2012 The Pan African 
Medical Journal 
27 Raza, S et al. Breast cancer in Pakistan: 
identifying local beliefs and 
knowledge. 
Quantitative 2012 Journal of the 
American 
College of 
Radiology 
28 Samson, B et al. Lived in experience of women 
with breast cancer. 
Qualitative 2016 Asian Journal of 
Pharmaceutical 
and Clinical 
Research 
29 Şengün, İ et al. Experiences of Turkish 
survivors of breast cancer: 
Neuman systems model 
perspective. 
Qualitative 2016 Japan Journal of 
Nursing Science 
30 Shaheen, R et al. Barriers and opportunities for 
early detection of breast cancer 
in Gaza women. 
Qualitative 2011 The Breast 
31 Suwankhong, D 
et al. 
Breast Cancer Treatment: 
Experiences of Changes and 
Social Stigma Among Thai 
Women in Southern Thailand. 
Qualitative 2016 Cancer Nursing 
32 Taha, H et al. 'Would a man smell a rose then 
throw it away?' Jordanian men's 
perspectives on women's 
breast cancer and breast 
health. 
Qualitative 2013 BMC Women's 
Health 
33 Taha, H et al. "Voices of fear and safety" 
women's ambivalence towards 
breast cancer and breast 
health: a qualitative study from 
Jordan. 
Qualitative 2012 BMC Women's 
Health 
34 Taib, N.A. et al Recognising symptoms of 
breast cancer as a reason for 
Qualitative 2011 Asian Pacific 
Journal of 
93 
 
 
delayed presentation in Asian 
women--the psycho-socio-
cultural model for breast 
symptom appraisal: 
opportunities for intervention. 
Cancer 
Prevention 
35 Taleghani F. et al. Coping with breast cancer in 
newly diagnosed Iranian 
women. 
Qualitative 2006 Journal of 
Advanced 
Nursing 
36 Tripathi, L et al. Stigma Perceived by Women 
Following Surgery for Breast 
Cancer. 
Quantitative 2017 Indian Journal of 
Medical and 
Paediatric 
Oncology 
37 Wigginton, B et al. Death, contagion and shame: 
The potential of cancer 
survivors' advocacy in Zambia. 
Qualitative 2018 Health care for 
Women 
International 
38 Wright, S.V. An investigation into the causes 
of absconding among black 
African breast cancer patients. 
Qualitative 1997 South African 
Medical Journal 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX 7: ASSOCIATIONS ANALYSIS FOR SYSTEMATIC REVIEW 
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Table 1. Association between Continent of Study and Stigma/Sociocultural Factor Rates 
 
 
 
 Continent  
 Africa Asia p-value 
Stigma 
Anticipated Yes 5  (41.7) 16  (61.5) 0.31 
No 7  (58.3) 10  (38.5)  
Experienced Yes 4  (33.3) 7  (26.9) 0.71 
No 8  (66.7) 19  (73.1)  
Layered Yes 2  (16.7) 1  (3.8) 0.23 
No 10  (83.3) 25  (96.2)  
Perceived Yes 8  (66.7) 13  (50) 0.49 
No 4  (33.3) 13  (50)  
Secondary Yes 2  (16.7) 6  (23.1) >0.95 
No 10  (83.3) 20  (76.9)  
Sociocultural Factors 
Collectivism Yes 1  (8.3) 1  (3.8) 0.54 
No 11  (91.7) 25  (96.2)  
Alternative 
Medicine 
Yes 7  (58.3) 4  (15.4) 0.017 
No 5  (41.7) 22  (84.6)  
Fatalism Yes 8  (66.7) 17  (65.4) >0.95 
No 4  (33.3) 9  (34.6)  
Myths Yes 9  (75) 9  (34.6) 0.035 
No 3  (25) 17  (65.4)  
Religious Yes 2  (16.7) 7  (26.9) 0.69 
No 10  (83.3) 19  (73.1)  
Fear of Surgery Yes 7  (58.3) 8  (30.8) 0.16 
No 5  (41.7) 18  (69.2)  
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Synopsis: 
This table presents the comparison of stigma and sociocultural factor rates between the two 
continents. No significant differences in stigma rates were noted between Asian countries and 
African countries (p=0.23->0.95). However, studies from Africa reported higher rates of 
alternative medicine use (58%, 7/12) compared to studies from Asia (15%, 4/26), p=0.017. 
Additionally, studies from Africa reported higher rates of myths (75%, 9/12) compared to Asian 
studies (35%, 9/26), p=0.035. No other significant differences were noted in sociocultural factors 
(p=0.16->0.95). 
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Table 2. Association between Region of Study and Stigma/Sociocultural Factor Rates 
 
 Region  
 Middle East and India Other p-value 
Stigma 
Anticipated Yes 13  (56.5) 8  (53.3) >0.95 
No 10  (43.5) 7  (46.7)  
Experienced Yes 7  (30.4) 4  (26.7) >0.95 
No 16  (69.6) 11  (73.3)  
Layered Yes 1  (4.3) 2  (13.3) 0.55 
No 22  (95.7) 13  (86.7)  
Perceived Yes 11  (47.8) 10  (66.7) 0.33 
No 12  (52.2) 5  (33.3)  
Secondary Yes 5  (21.7) 3  (20) >0.95 
No 18  (78.3) 12  (80)  
Sociocultural Factors 
Collectivism Yes 1  (4.3) 1  (6.7) >0.95 
No 22  (95.7) 14  (93.3)  
Alternative 
Medicine 
Yes 2  (8.7) 9  (60) 0.001 
No 21  (91.3) 6  (40)  
Fatalism Yes 15  (65.2) 10  (66.7) >0.95 
No 8  (34.8) 5  (33.3)  
Myths Yes 9  (39.1) 9  (60) 0.32 
No 14  (60.9) 6  (40)  
Religious Yes 7  (30.4) 2  (13.3) 0.27 
No 16  (69.6) 13  (86.7)  
Fear of Surgery Yes 6  (26.1) 9  (60) 0.049 
No 17  (73.9) 6  (40)  
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Synopsis 
• This table presents the stigma and sociocultural factor proportions by region. Other countries include all 
those in West, East, and South Africa and East Asian countries. Similar to the continent breakdown, no 
significant differences in stigma were noted (p=0.33->0.95), and alternative medicine rates were higher 
in other countries (60%, 9/15) compared to the Middle Eastern countries and India (9%, 2/23), p=0.001. 
Additionally, fear of surgery was marginally higher in other countries (60%, 9/15) compared to Middle 
Eastern countries and India (26%, 6/23), p=0.049. No significant differences in myth rates (p=0.32) or 
other sociocultural factors were found (p=0.27->0.95). 
99 
 
Table 3. Association between Rural Study Participants and Stigma/Sociocultural Factor Rates 
 
 Rural Study Participants  
 No Rural Sample Rural Sample p-value 
Stigma 
Anticipated Yes 11  (57.9) 4  (33.3) 0.27 
No 8  (42.1) 8  (66.7)  
Experienced Yes 6  (31.6) 3  (25) >0.95 
No 13  (68.4) 9  (75)  
Layered Yes 2  (10.5) 1  (8.3) >0.95 
No 17  (89.5) 11  (91.7)  
Perceived Yes 11  (57.9) 8  (66.7) 0.72 
No 8  (42.1) 4  (33.3)  
Secondary Yes 4  (21.1) 3  (25) >0.95 
No 15  (78.9) 9  (75)  
Sociocultural Factors 
Collectivism Yes 2  (10.5) 0  (0) 0.51 
No 17  (89.5) 12  (100)  
Alternative Medicine Yes 8  (42.1) 2  (16.7) 0.24 
No 11  (57.9) 10  (83.3)  
Fatalism Yes 15  (78.9) 6  (50) 0.13 
No 4  (21.1) 6  (50)  
Myths Yes 11  (57.9) 6  (50) 0.72 
No 8  (42.1) 6  (50)  
Religious Yes 5  (26.3) 2  (16.7) 0.68 
No 14  (73.7) 10  (83.3)  
Fear of Surgery Yes 8  (42.1) 7  (58.3) 0.47 
No 11  (57.9) 5  (41.7)  
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Synopsis 
This table presents the comparison of stigma and sociocultural factor rates between the rural 
study settings. No significant differences in stigma rates were found between studies that 
included rural participants and those that did not (p=0.27->0.95). Similarly, no significant 
differences were found in the rates of sociocultural factors (p=0.13-0.68).
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Table 4. Association between Including Breast Cancer Patients and Stigma/Sociocultural Factor Rates 
 
 
Breast Cancer Patients 
Included  
 No Yes p-value 
Stigma 
Anticipated Yes 6  (46.2) 15  (60) 0.50 
No 7  (53.8) 10  (40)  
Experienced Yes 1  (7.7) 10  (40) 0.060 
No 12  (92.3) 15  (60)  
Layered Yes 1  (7.7) 2  (8) >0.95 
No 12  (92.3) 23  (92)  
Perceived Yes 9  (69.2) 12  (48) 0.31 
No 4  (30.8) 13  (52)  
Secondary Yes 2  (15.4) 6  (24) 0.69 
No 11  (84.6) 19  (76)  
Sociocultural Factors 
Collectivism Yes 1  (7.7) 1  (4) >0.95 
No 12  (92.3) 24  (96)  
Alternative 
Medicine 
Yes 2  (15.4) 9  (36) 0.27 
No 11  (84.6) 16  (64)  
Fatalism Yes 8  (61.5) 17  (68) 0.73 
No 5  (38.5) 8  (32)  
Myths Yes 8  (61.5) 10  (40) 0.31 
No 5  (38.5) 15  (60)  
Religious Yes 6  (46.2) 3  (12) 0.040 
No 7  (53.8) 22  (88)  
Fear of Surgery Yes 6  (46.2) 9  (36) 0.73 
No 7  (53.8) 16  (64)  
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Synopsis 
This table presents the comparison of stigma and sociocultural factor rates between studies that 
included breast cancer patients and those that did not. No significant differences in stigma rates 
were noted between these studies, although experienced stigma approached significance 
(p=0.060, others p=0.31->0.95). Studies that included breast cancer patients had higher rates of 
experienced stigma (40%, 10/25) compared to studies that did not include any breast cancer 
patients (8%, 1/13). Studies that did not include breast cancer patients reported higher rates of 
religious sociocultural factor (46%, 6/13) compared to studies that included breast cancer 
patients (12%, 3/25), p=0.040. No other significant differences in sociocultural factors were 
found (p=0.31->0.95).
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Table 5. Association between Publication Year and Stigma/Sociocultural Factor Rates 
 
 Publication Year  
 pre-2010 2010-2014 2014-2018 p-value 
Stigma 
Anticipated Yes 2  (40) 13  (56.5) 6  (60) 0.80 
No 3  (60) 10  (43.5) 4  (40)  
Experienced Yes 2  (40) 5  (21.7) 4  (40) 0.51 
No 3  (60) 18  (78.3) 6  (60)  
Layered Yes 1  (20) 1  (4.3) 1  (10) 0.34 
No 4  (80) 22  (95.7) 9  (90)  
Perceived Yes 4  (80) 10  (43.5) 7  (70) 0.26 
No 1  (20) 13  (56.5) 3  (30)  
Secondary Yes 0  (0) 5  (21.7) 3  (30) 0.54 
No 5  (100) 18  (78.3) 7  (70)  
Sociocultural Factors 
Collectivism Yes 1  (20) 1  (4.3) 0  (0) 0.31 
No 4  (80) 22  (95.7) 10  (100)  
Alternative Medicine Yes 3  (60) 5  (21.7) 3  (30) 0.21 
No 2  (40) 18  (78.3) 7  (70)  
Fatalism Yes 3  (60) 15  (65.2) 7  (70) >0.95 
No 2  (40) 8  (34.8) 3  (30)  
Myths Yes 3  (60) 11  (47.8) 4  (40) 0.81 
No 2  (40) 12  (52.2) 6  (60)  
Religious Yes 2  (40) 7  (30.4) 0  (0) 0.10 
No 3  (60) 16  (69.6) 10  (100)  
Fear of Surgery Yes 3  (60) 9  (39.1) 3  (30) 0.51 
No 2  (40) 14  (60.9) 7  (70)  
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Synopsis 
This table presents the comparison of stigma and sociocultural factor rates by publication year. 
No significant differences were found in stigma rates (p=0.26-0.80) or sociocultural factors 
(p=0.10->0.95).
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 Table 6. Association between Anticipated Stigma and Sociocultural Factor Rates 
 
 Anticipated Stigma  
 No Yes p-value 
Sociocultural Factors 
Collectivism Yes 1  (5.9) 1  (4.8) >0.95 
No 16  (94.1) 20  (95.2)  
Alternative 
Medicine 
Yes 6  (35.3) 5  (23.8) 0.49 
No 11  (64.7) 16  (76.2)  
Fatalism Yes 12  (70.6) 13  (61.9) 0.73 
No 5  (29.4) 8  (38.1)  
Myths Yes 10  (58.8) 8  (38.1) 0.33 
No 7  (41.2) 13  (61.9)  
Religious Yes 2  (11.8) 7  (33.3) 0.15 
No 15  (88.2) 14  (66.7)  
Fear of Surgery Yes 6  (35.3) 9  (42.9) 0.74 
No 11  (64.7) 12  (57.1)  
 
 
 
Synopsis 
This table presents the relationship between anticipated stigma and sociocultural factors. No 
significant differences were found between studies that had anticipated stigma and those that 
did not (p=0.15->0.95).
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 Table 7. Association between Experienced Stigma and Sociocultural Factor Rates 
 
 Experienced Stigma  
 No Yes 
p-
value 
Sociocultural Factors 
Collectivism Yes 2  (7.4) 0  (0) >0.95 
No 25  (92.6) 11  (100)  
Alternative 
Medicine 
Yes 9  (33.3) 2  (18.2) 0.45 
No 18  (66.7) 9  (81.8)  
Fatalism Yes 17  (63) 8  (72.7) 0.71 
No 10  (37) 3  (27.3)  
Myths Yes 13  (48.1) 5  (45.5) >0.95 
No 14  (51.9) 6  (54.5)  
Religious Yes 8  (29.6) 1  (9.1) 0.24 
No 19  (70.4) 10  (90.9)  
Fear of Surgery Yes 11  (40.7) 4  (36.4) >0.95 
No 16  (59.3) 7  (63.6)  
 
 
 
Synopsis 
 
This table presents the relationship between experienced stigma and sociocultural factors. No 
significant differences were found between studies that had experienced stigma and those that 
did not (p=0.24->0.95).
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 Table 8. Association between Layered Stigma and Sociocultural Factor Rates 
 
 Layered Stigma  
 No Yes 
p-
value 
Sociocultural Factors 
Collectivism Yes 2  (5.7) 0  (0) >0.95 
No 33  (94.3) 3  (100)  
Alternative 
Medicine 
Yes 9  (25.7) 2  (66.7) 0.20 
No 26  (74.3) 1  (33.3)  
Fatalism Yes 24  (68.6) 1  (33.3) 0.27 
No 11  (31.4) 2  (66.7)  
Myths Yes 17  (48.6) 1  (33.3) >0.95 
No 18  (51.4) 2  (66.7)  
Religious Yes 8  (22.9) 1  (33.3) >0.95 
No 27  (77.1) 2  (66.7)  
Fear of Surgery Yes 13  (37.1) 2  (66.7) 0.55 
No 22  (62.9) 1  (33.3)  
 
 
 
Synopsis 
This table presents the relationship between layered stigma and sociocultural factors. No 
significant differences were found between studies that had layered stigma and those that did 
not (p=0.20->0.95).
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 Table 9. Association between Perceived Stigma and Sociocultural Factor Rates 
 
 Perceived Stigma  
 No Yes 
p-
value 
Sociocultural Factors 
Collectivism Yes 0  (0) 2  (9.5) 0.49 
No 17  (100) 19  (90.5)  
Alternative 
Medicine 
Yes 1  (5.9) 10  (47.6) 0.010 
No 16  (94.1) 11  (52.4)  
Fatalism Yes 10  (58.8) 15  (71.4) 0.50 
No 7  (41.2) 6  (28.6)  
Myths Yes 6  (35.3) 12  (57.1) 0.21 
No 11  (64.7) 9  (42.9)  
Religious Yes 3  (17.6) 6  (28.6) 0.48 
No 14  (82.4) 15  (71.4)  
Fear of Surgery Yes 5  (29.4) 10  (47.6) 0.33 
No 12  (70.6) 11  (52.4)  
 
 
 
Synopsis 
This table presents the relationship between perceived stigma and sociocultural factors. Studies 
that had perceived stigma had higher rates of alternative medicine use (48%, 10/21) than 
studies that did not have perceived stigma (6%, 1/17). No other significant differences were 
found between studies that had perceived stigma and those that did not (p=0.21->0.95).
110 
 Table 10. Association between Secondary Stigma and Sociocultural Factor Rates 
 Secondary Stigma  
 No Yes 
p-
value 
Sociocultural Factors 
Collectivism Yes 2  (6.7) 0  (0) >0.95 
No 28  (93.3) 8  (100)  
Alternative 
Medicine 
Yes 9  (30) 2  (25) >0.95 
No 21  (70) 6  (75)  
Fatalism Yes 18  (60) 7  (87.5) 0.22 
No 12  (40) 1  (12.5)  
Myths Yes 15  (50) 3  (37.5) 0.70 
No 15  (50) 5  (62.5)  
Religious Yes 8  (26.7) 1  (12.5) 0.65 
No 22  (73.3) 7  (87.5)  
Fear of Surgery Yes 12  (40) 3  (37.5) >0.95 
No 18  (60) 5  (62.5)  
 
 
 
Synopsis 
This table presents the relationship between secondary stigma and sociocultural 
factors. No significant differences were found between studies that had secondary 
stigma and those that did not (p=0.22->0.95). 
 
 
 
 
 
 
 
 
